Functional	O
replacement	O
of	O
the	O
mouse	B-DNA
E2A	I-DNA
gene	I-DNA
with	O
a	O
human	B-DNA
HEB	I-DNA
cDNA	I-DNA
.	O

The	O
mammalian	B-DNA
E2A	I-DNA
,	I-DNA
HEB	I-DNA
,	I-DNA
and	I-DNA
E2-2	I-DNA
genes	I-DNA
encode	O
a	O
unique	O
class	O
of	O
basic	B-protein
helix-loop-helix	I-protein
(	I-protein
bHLH	I-protein
)	I-protein
transcription	I-protein
factors	I-protein
that	O
are	O
evolutionarily	O
conserved	O
and	O
essential	O
for	O
embryonic	O
and	O
postnatal	O
development	O
.	O

While	O
the	O
structural	O
and	O
functional	O
similarities	O
among	O
the	O
gene	B-protein
products	I-protein
are	O
well	O
demonstrated	O
,	O
it	O
is	O
not	O
clear	O
why	O
deletion	O
of	O
E2A	B-DNA
,	O
but	O
not	O
HEB	B-DNA
or	O
E2-2	B-DNA
,	O
leads	O
to	O
a	O
complete	O
arrest	O
in	O
B-lymphocyte	O
development	O
.	O

To	O
understand	O
the	O
molecular	O
basis	O
of	O
the	O
functional	O
specificity	O
between	O
E2A	B-DNA
and	O
HEB	B-DNA
/	O
E2-2	B-DNA
in	O
mammalian	O
development	O
,	O
we	O
generated	O
and	O
tested	O
a	O
panel	O
of	O
E2A	B-DNA
knockin	O
mutations	O
including	O
subtle	O
mutations	O
in	O
the	O
E12	B-DNA
and	I-DNA
E47	I-DNA
exons	I-DNA
and	O
substitution	O
of	O
both	O
E12	B-DNA
and	I-DNA
E47	I-DNA
exons	I-DNA
with	O
a	O
human	B-DNA
HEB	I-DNA
cDNA	I-DNA
.	O

We	O
find	O
that	O
the	O
alternatively	O
spliced	O
E12	B-protein
and	I-protein
E47	I-protein
bHLH	I-protein
proteins	I-protein
of	O
the	O
E2A	B-DNA
gene	I-DNA
play	O
similar	O
and	O
additive	O
roles	O
in	O
supporting	O
B	B-cell_type
lymphopoiesis	I-cell_type
.	O

Further	O
,	O
we	O
find	O
that	O
HEB	B-DNA
driven	O
by	O
the	O
endogenous	B-DNA
E2A	I-DNA
promoter	I-DNA
can	O
functionally	O
replace	O
E2A	B-DNA
in	O
supporting	O
B-cell	O
commitment	O
and	O
differentiation	O
toward	O
completion	O
.	O

Finally	O
,	O
the	O
postnatal	O
lethality	O
associated	O
with	O
E2A	B-DNA
disruption	O
is	O
fully	O
rescued	O
by	O
the	O
addition	O
of	O
HEB	B-DNA
.	O

This	O
study	O
suggests	O
that	O
the	O
functional	O
divergence	O
among	O
E12	B-DNA
,	O
E47	B-DNA
,	O
and	O
HEB	B-DNA
in	O
different	O
cell	O
types	O
is	O
partially	O
defined	O
by	O
the	O
context	O
of	O
gene	O
expression	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
June	NULL
1998	NULL
,	NULL
p.	NULL
3340-3349	NULL
0270-7306/98/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

6	NULL
Functional	NULL
Replacement	NULL
of	NULL
the	NULL
Mouse	NULL
E2A	NULL
Gene	NULL
with	NULL
a	NULL
Human	NULL
HEB	NULL
cDNA	NULL
YUAN	NULL
ZHUANG	NULL
,	NULL
*	NULL
ROBERT	NULL
J.	NULL
BARNDT	NULL
,	NULL
LIHUA	NULL
PAN	NULL
,	NULL
ROBERT	NULL
KELLEY	NULL
,	NULL
AND	NULL
MEIFANG	NULL
DAI	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Duke	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Durham	NULL
,	NULL
North	NULL
Carolina	NULL
27710	NULL
Received	NULL
11	NULL
December	NULL
1997/Returned	NULL
for	NULL
modification	NULL
29	NULL
January	NULL
1998/Accepted	NULL
24	NULL
February	NULL
1998	NULL
The	NULL
mammalian	NULL
E2A	NULL
,	NULL
HEB	NULL
,	NULL
and	NULL
E2-2	NULL
genes	NULL
encode	NULL
a	NULL
unique	NULL
class	NULL
of	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
evolutionarily	NULL
conserved	NULL
and	NULL
essential	NULL
for	NULL
embryonic	NULL
and	NULL
postnatal	NULL
development	NULL
.	NULL

While	NULL
the	NULL
structural	NULL
and	NULL
functional	NULL
similarities	NULL
among	NULL
the	NULL
gene	NULL
products	NULL
are	NULL
well	NULL
demonstrated	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
why	NULL
deletion	NULL
of	NULL
E2A	NULL
,	NULL
but	NULL
not	NULL
HEB	NULL
or	NULL
E2-2	NULL
,	NULL
leads	NULL
to	NULL
a	NULL
complete	NULL
arrest	NULL
in	NULL
B-lymphocyte	NULL
development	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
functional	NULL
specificity	NULL
between	NULL
E2A	NULL
and	NULL
HEB/E2-2	NULL
in	NULL
mammalian	NULL
development	NULL
,	NULL
we	NULL
generated	NULL
and	NULL
tested	NULL
a	NULL
panel	NULL
of	NULL
E2A	NULL
knockin	NULL
mutations	NULL
including	NULL
subtle	NULL
mutations	NULL
in	NULL
the	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
and	NULL
substitution	NULL
of	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
with	NULL
a	NULL
human	NULL
HEB	NULL
cDNA	NULL
.	NULL

We	NULL
find	NULL
that	NULL
the	NULL
alternatively	NULL
spliced	NULL
E12	NULL
and	NULL
E47	NULL
bHLH	NULL
proteins	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
play	NULL
similar	NULL
and	NULL
additive	NULL
roles	NULL
in	NULL
supporting	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

Further	NULL
,	NULL
we	NULL
find	NULL
that	NULL
HEB	NULL
driven	NULL
by	NULL
the	NULL
endogenous	NULL
E2A	NULL
promoter	NULL
can	NULL
functionally	NULL
replace	NULL
E2A	NULL
in	NULL
supporting	NULL
B-cell	NULL
commitment	NULL
and	NULL
differentiation	NULL
toward	NULL
completion	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
postnatal	NULL
lethality	NULL
associated	NULL
with	NULL
E2A	NULL
disruption	NULL
is	NULL
fully	NULL
rescued	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
HEB	NULL
.	NULL

This	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
functional	NULL
divergence	NULL
among	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
HEB	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
is	NULL
partially	NULL
defined	NULL
by	NULL
the	NULL
context	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

B	NULL
lymphocytes	NULL
in	NULL
mammals	NULL
are	NULL
derived	NULL
from	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
HSC	NULL
)	NULL
present	NULL
in	NULL
the	NULL
liver	NULL
during	NULL
fetal	NULL
development	NULL
and	NULL
bone	NULL
marrow	NULL
in	NULL
adult	NULL
life	NULL
.	NULL

The	NULL
same	NULL
HSC	NULL
also	NULL
generate	NULL
T	NULL
lymphocytes	NULL
,	NULL
erythrocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
in	NULL
blood	NULL
and	NULL
the	NULL
lymphoid	NULL
organs	NULL
.	NULL

Once	NULL
committed	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
the	NULL
HSC	NULL
follow	NULL
a	NULL
stepwise	NULL
differentiation	NULL
pathway	NULL
to	NULL
become	NULL
B	NULL
lymphocytes	NULL
,	NULL
which	NULL
subsequently	NULL
participate	NULL
in	NULL
diverse	NULL
humoral	NULL
immune	NULL
responses	NULL
.	NULL

It	NULL
is	NULL
not	NULL
entirely	NULL
known	NULL
how	NULL
and	NULL
when	NULL
B-lineage	NULL
cells	NULL
are	NULL
first	NULL
specified	NULL
from	NULL
HSC	NULL
and	NULL
how	NULL
B	NULL
lymphopoiesis	NULL
is	NULL
maintained	NULL
throughout	NULL
life	NULL
.	NULL

B-lineage	NULL
development	NULL
can	NULL
be	NULL
divided	NULL
roughly	NULL
into	NULL
three	NULL
discrete	NULL
stages	NULL
:	NULL
progenitor	NULL
(	NULL
pro-B	NULL
)	NULL
,	NULL
precursor	NULL
(	NULL
pre-B	NULL
)	NULL
,	NULL
and	NULL
mature	NULL
B-cell	NULL
stages	NULL
.	NULL

Rearrangements	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
genes	NULL
initiate	NULL
at	NULL
the	NULL
pro-B	NULL
stage	NULL
and	NULL
proceed	NULL
to	NULL
completion	NULL
at	NULL
the	NULL
pre-B	NULL
stage	NULL
.	NULL

Pre-B	NULL
cells	NULL
expressing	NULL
functional	NULL
but	NULL
nonself-reactive	NULL
B-cell	NULL
receptors	NULL
are	NULL
selected	NULL
for	NULL
survival	NULL
and	NULL
expansion	NULL
to	NULL
become	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
B	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
express	NULL
lineage-specific	NULL
markers	NULL
,	NULL
such	NULL
as	NULL
B220	NULL
,	NULL
CD43	NULL
,	NULL
and	NULL
CD19	NULL
surface	NULL
antigens	NULL
(	NULL
9	NULL
,	NULL
19	NULL
)	NULL
.	NULL

These	NULL
lineage	NULL
markers	NULL
,	NULL
combined	NULL
with	NULL
the	NULL
status	NULL
of	NULL
Ig	NULL
rearrangements	NULL
and	NULL
expression	NULL
,	NULL
establish	NULL
road	NULL
signs	NULL
of	NULL
normal	NULL
and	NULL
abnormal	NULL
progression	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Regulation	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
is	NULL
crucial	NULL
in	NULL
each	NULL
step	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

Indeed	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
E2A	NULL
,	NULL
EBF	NULL
,	NULL
Pax5	NULL
,	NULL
Ikaros	NULL
,	NULL
and	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
play	NULL
key	NULL
roles	NULL
in	NULL
the	NULL
pro-	NULL
and	NULL
pre-B	NULL
stages	NULL
of	NULL
development	NULL
(	NULL
2	NULL
,	NULL
14	NULL
,	NULL
29	NULL
,	NULL
31	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
genes	NULL
encoding	NULL
each	NULL
one	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
arrests	NULL
B-cell	NULL
development	NULL
at	NULL
either	NULL
the	NULL
pro-	NULL
or	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

Since	NULL
deletion	NULL
of	NULL
E2A	NULL
blocks	NULL
B-cell	NULL
development	NULL
prior	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
Ig	NULL
gene	NULL
rearrange-ment	NULL
,	NULL
E2A	NULL
seems	NULL
to	NULL
play	NULL
an	NULL
extremely	NULL
early	NULL
role	NULL
.	NULL

Furthermore	NULL
,	NULL
E2A	NULL
is	NULL
the	NULL
only	NULL
gene	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
triggering	NULL
Ig	NULL
gene	NULL
D-J	NULL
rearrangement	NULL
in	NULL
non-B	NULL
cells	NULL
,	NULL
making	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Duke	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
27710	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
919	NULL
)	NULL
613-7824	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
919	NULL
)	NULL
684-8982	NULL
.	NULL

E-mail	NULL
:	NULL
yzhuang	NULL
@	NULL
acpub.duke	NULL
.edu	NULL
.	NULL

3340	NULL
E2A	NULL
a	NULL
key	NULL
regulatory	NULL
component	NULL
for	NULL
B-lineage	NULL
commitment	NULL
(	NULL
6	NULL
,	NULL
23	NULL
)	NULL
.	NULL

E2A	NULL
is	NULL
a	NULL
founding	NULL
member	NULL
of	NULL
the	NULL
basic-helix-loop-helix	NULL
(	NULL
bHLH	NULL
]	NULL
)	NULL
gene	NULL
family	NULL
,	NULL
which	NULL
is	NULL
defined	NULL
by	NULL
the	NULL
conserved	NULL
bHLH	NULL
structure	NULL
,	NULL
a	NULL
protein	NULL
domain	NULL
involved	NULL
in	NULL
DNA	NULL
binding	NULL
and	NULL
protein	NULL
dimerization	NULL
.	NULL

EZ2A	NULL
encodes	NULL
two	NULL
bHLH	NULL
proteins	NULL
,	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
which	NULL
contain	NULL
different	NULL
bHLH	NULL
domains	NULL
resulting	NULL
from	NULL
alternative	NULL
splicing	NULL
(	NULL
15	NULL
,	NULL
27	NULL
)	NULL
.	NULL

E12	NULL
and	NULL
E47	NULL
,	NULL
together	NULL
with	NULL
the	NULL
gene	NULL
products	NULL
of	NULL
the	NULL
E2-2	NULL
and	NULL
HEB	NULL
genes	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
comprise	NULL
a	NULL
unique	NULL
subfamily	NULL
of	NULL
bHLH	NULL
proteins	NULL
,	NULL
commonly	NULL
known	NULL
as	NULL
the	NULL
E-protein	NULL
family	NULL
.	NULL

These	NULL
E	NULL
proteins	NULL
are	NULL
ubiquitously	NULL
,	NULL
although	NULL
not	NULL
evenly	NULL
,	NULL
expressed	NULL
and	NULL
are	NULL
capable	NULL
of	NULL
forming	NULL
heterodimers	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
bHLH	NULL
proteins	NULL
,	NULL
including	NULL
tissue-specific	NULL
bHLH	NULL
proteins	NULL
such	NULL
as	NULL
MyoD	NULL
(	NULL
13	NULL
,	NULL
16	NULL
)	NULL
and	NULL
broadly	NULL
expressed	NULL
inhibitory	NULL
proteins	NULL
such	NULL
as	NULL
Id1	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
large	NULL
body	NULL
of	NULL
evidence	NULL
indicates	NULL
that	NULL
E2A	NULL
proteins	NULL
participate	NULL
in	NULL
tissue-specific	NULL
regulation	NULL
through	NULL
heterodimer	NULL
formation	NULL
with	NULL
the	NULL
tissue-specific	NULL
bHLH	NULL
proteins	NULL
(	NULL
13	NULL
,	NULL
16	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
of	NULL
E2A	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
Id	NULL
proteins	NULL
that	NULL
dimerize	NULL
with	NULL
E2A	NULL
and	NULL
form	NULL
a	NULL
non-DNA	NULL
binding	NULL
heterodimer	NULL
(	NULL
4	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
E2A	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
tissue-specific	NULL
gene	NULL
regulation	NULL
by	NULL
mediating	NULL
positive	NULL
and	NULL
negative	NULL
signals	NULL
.	NULL

However	NULL
,	NULL
gene	NULL
knockout	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
generic	NULL
function	NULL
of	NULL
E2A	NULL
may	NULL
not	NULL
be	NULL
provided	NULL
by	NULL
E2A	NULL
alone	NULL
,	NULL
since	NULL
most	NULL
tissue	NULL
types	NULL
and	NULL
organs	NULL
can	NULL
develop	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
(	NULL
2	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
EZA	NULL
in	NULL
B-cell	NULL
development	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
EZA	NULL
protein	NULL
homodimers	NULL
.	NULL

Studies	NULL
have	NULL
demonstrated	NULL
that	NULL
E47	NULL
is	NULL
capable	NULL
of	NULL
forming	NULL
homodimers	NULL
in	NULL
the	NULL
physiological	NULL
conditions	NULL
of	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
5	NULL
,	NULL
25	NULL
)	NULL
.	NULL

EA47	NULL
homodimerization	NULL
is	NULL
regulated	NULL
posttranslationally	NULL
through	NULL
at	NULL
least	NULL
two	NULL
possible	NULL
means	NULL
:	NULL
a	NULL
disulfide	NULL
bond	NULL
can	NULL
covalently	NULL
link	NULL
two	NULL
monomers	NULL
and	NULL
prevent	NULL
dimer	NULL
dissociation	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
hypo-phosphorylation	NULL
at	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
basic	NULL
domain	NULL
may	NULL
enhance	NULL
homodimer	NULL
formation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
generally	NULL
believed	NULL
that	NULL
the	NULL
initiation	NULL
and	NULL
maintenance	NULL
of	NULL
E47	NULL
homodimers	NULL
in	NULL
B	NULL
cells	NULL
underlies	NULL
the	NULL
specificity	NULL
of	NULL
E2A	NULL
function	NULL
in	NULL
B-cell	NULL
development	NULL
.	NULL

E12	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
does	NULL
not	NULL
form	NULL
homodimers	NULL
because	NULL
of	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
an	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
TABLE	NULL
1	NULL
.	NULL

PCR	NULL
primer	NULL
sequences	NULL
Name	NULL
Sequence	NULL
Location	NULL
YZ-104	NULL
-	NULL
5'-ATG	NULL
TGT	NULL
GGT	NULL
GGC	NULL
CCA	NULL
CAC	NULL
TTG	NULL
T-3	NULL
'	NULL
YZ-177	NULL
-	NULL
TGG	NULL
ACA	NULL
TTT	NULL
TCT	NULL
AGG	NULL
CAG-3	NULL
'	NULL
YZ-164	NULL
5'-AAG	NULL
AAC	NULL
GAG	NULL
GCC	NULL
TTC	NULL
CGT	NULL
GTC-3	NULL
'	NULL
E2A	NULL
sense	NULL
E19	NULL
5	NULL
``	NULL
-CCG	NULL
AGC	NULL
TCC	NULL
TTA	NULL
AAG	NULL
GCC	NULL
TCA-3	NULL
'	NULL
E12	NULL
antisense	NULL
E21	NULL
5	NULL
``	NULL
-CAG	NULL
TAC	NULL
AGA	NULL
TGA	NULL
GGT	NULL
GCT	NULL
GTC	NULL
C-3	NULL
'	NULL
E47	NULL
sense	NULL
YZ-24	NULL
-	NULL
5-GTT	NULL
GTG	NULL
CCC	NULL
AGT	NULL
CAT	NULL
AGC	NULL
CG-3	NULL
'	NULL
Neo	NULL
antisense	NULL
YZ-29	NULL
-	NULL
5-TCG	NULL
CAG	NULL
CGC	NULL
ATC	NULL
GCC	NULL
TTC	NULL
TA-3	NULL
'	NULL
Neo	NULL
sense	NULL
E2A	NULL
antisense	NULL
E2A	NULL
sense	NULL
acidic	NULL
region	NULL
adjacent	NULL
to	NULL
the	NULL
bHLH	NULL
domain	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
has	NULL
suggested	NULL
that	NULL
E12	NULL
may	NULL
collaborate	NULL
with	NULL
E47	NULL
in	NULL
supporting	NULL
B-lineage	NULL
commitment	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
this	NULL
cooperation	NULL
between	NULL
E12	NULL
and	NULL
E47	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
function	NULL
of	NULL
E2-2	NULL
and	NULL
HEB	NULL
in	NULL
B-cell	NULL
development	NULL
has	NULL
also	NULL
been	NULL
investigated	NULL
through	NULL
targeted	NULL
mutation	NULL
in	NULL
mice	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
either	NULL
E2-2	NULL
or	NULL
HEB	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
E2A	NULL
mutation	NULL
,	NULL
are	NULL
still	NULL
able	NULL
to	NULL
generate	NULL
substantial	NULL
amounts	NULL
of	NULL
B-lineage	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
neither	NULL
E2-2	NULL
nor	NULL
HEB	NULL
is	NULL
essential	NULL
to	NULL
B-cell	NULL
commitment	NULL
and	NULL
maturation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
number	NULL
of	NULL
pro-B	NULL
cells	NULL
produced	NULL
in	NULL
E2-2	NULL
or	NULL
HEB	NULL
mutant	NULL
mice	NULL
is	NULL
slightly	NULL
reduced	NULL
and	NULL
can	NULL
be	NULL
reduced	NULL
further	NULL
in	NULL
the	NULL
compound-heterozygous	NULL
background	NULL
of	NULL
EZA	NULL
and	NULL
E2-2	NULL
or	NULL
E2A	NULL
and	NULL
HEB	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
have	NULL
proposed	NULL
that	NULL
E2-2	NULL
and	NULL
HEB	NULL
can	NULL
modulate	NULL
,	NULL
but	NULL
may	NULL
not	NULL
replace	NULL
,	NULL
EZ2A	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
interaction	NULL
between	NULL
EZA	NULL
and	NULL
E2-2	NULL
or	NULL
HEB	NULL
is	NULL
due	NULL
to	NULL
titration	NULL
of	NULL
the	NULL
Id	NULL
proteins	NULL
,	NULL
the	NULL
common	NULL
dimerization	NULL
partners	NULL
of	NULL
all	NULL
E	NULL
proteins	NULL
(	NULL
28	NULL
,	NULL
36	NULL
)	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
functional	NULL
specificity	NULL
of	NULL
individual	NULL
E	NULL
proteins	NULL
in	NULL
B-cell	NULL
development	NULL
,	NULL
we	NULL
generated	NULL
and	NULL
analyzed	NULL
a	NULL
panel	NULL
of	NULL
E2A	NULL
mutations	NULL
.	NULL

First	NULL
,	NULL
we	NULL
used	NULL
gene	NULL
targeting	NULL
to	NULL
convert	NULL
the	NULL
endogenous	NULL
E47	NULL
into	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
by	NULL
introducing	NULL
a	NULL
point	NULL
mutation	NULL
into	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
the	NULL
bHLH	NULL
domain	NULL
of	NULL
E47	NULL
.	NULL

This	NULL
mutation	NULL
,	NULL
together	NULL
with	NULL
a	NULL
previously	NULL
generated	NULL
E12	NULL
knockout	NULL
allele	NULL
,	NULL
demonstrated	NULL
that	NULL
either	NULL
E12	NULL
or	NULL
EA7	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
a	NULL
limited	NULL
,	NULL
but	NULL
definitive	NULL
,	NULL
B-lineage	NULL
commitment	NULL
.	NULL

However	NULL
,	NULL
a	NULL
sustained	NULL
and	NULL
optimal	NULL
B-cell	NULL
production	NULL
requires	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
used	NULL
a	NULL
knockin	NULL
approach	NULL
to	NULL
replace	NULL
the	NULL
mouse	NULL
EZA	NULL
gene	NULL
with	NULL
a	NULL
human	NULL
HEB	NULL
cDNA	NULL
.	NULL

When	NULL
the	NULL
HEB	NULL
cDNA	NULL
was	NULL
tested	NULL
on	NULL
the	NULL
E2A-null	NULL
background	NULL
,	NULL
we	NULL
found	NULL
that	NULL
two	NULL
copies	NULL
,	NULL
but	NULL
not	NULL
one	NULL
,	NULL
of	NULL
human	NULL
HEB	NULL
can	NULL
support	NULL
B-cell	NULL
development	NULL
.	NULL

This	NULL
study	NULL
demonstrates	NULL
that	NULL
E47	NULL
,	NULL
E12	NULL
,	NULL
and	NULL
HEB	NULL
have	NULL
similar	NULL
structural	NULL
features	NULL
required	NULL
for	NULL
B-cell	NULL
development	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
results	NULL
suggest	NULL
that	NULL
B-cell	NULL
commitment	NULL
and	NULL
maturation	NULL
are	NULL
regulated	NULL
by	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
E	NULL
proteins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
E47	NULL
``	NULL
and	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
alleles	NULL
.	NULL

The	NULL
E47Â°	NULL
``	NULL
(	NULL
basic-region	NULL
mutation	NULL
)	NULL
targeting	NULL
construct	NULL
was	NULL
built	NULL
on	NULL
a	NULL
9-kb	NULL
Kpnl-BamHI	NULL
fragment	NULL
of	NULL
the	NULL
E2A	NULL
genomic	NULL
DNA	NULL
isolated	NULL
from	NULL
the	NULL
129/sy	NULL
strain	NULL
.	NULL

A	NULL
2-kb	NULL
subclone	NULL
covering	NULL
the	NULL
E47	NULL
exon	NULL
was	NULL
used	NULL
in	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
Amersham	NULL
Sculptor	NULL
kit	NULL
)	NULL
for	NULL
introduction	NULL
of	NULL
the	NULL
E47	NULL
basic-region	NULL
mutation	NULL
.	NULL

The	NULL
mutation	NULL
was	NULL
verified	NULL
by	NULL
sequencing	NULL
before	NULL
subcloning	NULL
into	NULL
the	NULL
targeting	NULL
construct	NULL
.	NULL

A	NULL
phosphoglycerate	NULL
kinase	NULL
(	NULL
PGK	NULL
)	NULL
-neomycin	NULL
phosphoryltransferase	NULL
(	NULL
Neo	NULL
)	NULL
cassette	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
Xbel	NULL
site	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

A	NULL
(	NULL
PGK	NULL
)	NULL
-thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
cassette	NULL
was	NULL
placed	NULL
outside	NULL
the	NULL
targeting	NULL
module	NULL
and	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
selection	NULL
marker	NULL
to	NULL
eliminate	NULL
the	NULL
nonhomologous	NULL
recombination	NULL
events	NULL
.	NULL

A	NULL
separate	NULL
and	NULL
more	NULL
generic	NULL
targeting	NULL
vector	NULL
was	NULL
made	NULL
for	NULL
introducing	NULL
any	NULL
cDNA	NULL
sequence	NULL
into	NULL
the	NULL
E2A	NULL
locus	NULL
.	NULL

This	NULL
construct	NULL
contains	NULL
,	NULL
from	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
,	NULL
a	NULL
6-kb	NULL
E2A	NULL
homologous	NULL
sequence	NULL
,	NULL
the	NULL
Neo	NULL
coding	NULL
sequence	NULL
fused	NULL
in	NULL
frame	NULL
with	NULL
E2A	NULL
,	NULL
a	NULL
unique	NULL
cloning	NULL
site	NULL
for	NULL
introduction	NULL
of	NULL
foreign	NULL
cDNA	NULL
,	NULL
and	NULL
a	NULL
short	NULL
3	NULL
'	NULL
homologous	NULL
sequence	NULL
to	NULL
facilitate	NULL
PCR	NULL
detection	NULL
of	NULL
recombination	NULL
events	NULL
.	NULL

A	NULL
full-length	NULL
human	NULL
HEB	NULL
cDNA	NULL
(	NULL
11	NULL
)	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
Neo	NULL
marker	NULL
and	NULL
the	NULL
3	NULL
'	NULL
homologous	NULL
sequence	NULL
.	NULL

Translation	NULL
of	NULL
the	NULL
HEB	NULL
cDNA	NULL
was	NULL
provided	NULL
by	NULL
the	NULL
encephalomyocarditis	NULL
virus	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
added	NULL
in	NULL
front	NULL
of	NULL
the	NULL
HEB	NULL
cDNA	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
HEB	NULL
cDNA	NULL
was	NULL
provided	NULL
by	NULL
the	NULL
E2A	NULL
THRESHOLD	NULL
CONTROLS	NULL
B-CELL	NULL
LINEAGE	NULL
COMMITMENT	NULL
-	NULL
3341	NULL
endogenous	NULL
E2A	NULL
promoter	NULL
when	NULL
the	NULL
construct	NULL
was	NULL
integrated	NULL
into	NULL
the	NULL
EZA	NULL
locus	NULL
.	NULL

Gene	NULL
targeting	NULL
was	NULL
performed	NULL
in	NULL
an	NULL
embryonic	NULL
stem	NULL
(	NULL
ES	NULL
)	NULL
cell	NULL
line	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
A.	NULL
Imamoto	NULL
and	NULL
P.	NULL
Soriano	NULL
)	NULL
derived	NULL
from	NULL
a	NULL
129/svy	NULL
mouse	NULL
.	NULL

Clones	NULL
carrying	NULL
targeting	NULL
events	NULL
were	NULL
identified	NULL
by	NULL
PCR	NULL
and	NULL
subsequently	NULL
confirmed	NULL
by	NULL
Southern	NULL
analysis	NULL
.	NULL

Chimeric	NULL
mice	NULL
were	NULL
derived	NULL
by	NULL
injecting	NULL
ES	NULL
cells	NULL
into	NULL
blastocysts	NULL
harvested	NULL
from	NULL
C57BL/6	NULL
mice	NULL
.	NULL

Germ	NULL
line	NULL
transmission	NULL
was	NULL
tested	NULL
by	NULL
crossing	NULL
chimeric	NULL
males	NULL
with	NULL
C57BL/6	NULL
females	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
heterozygous	NULL
mice	NULL
were	NULL
maintained	NULL
thereafter	NULL
on	NULL
the	NULL
mixed	NULL
background	NULL
of	NULL
129/sv	NULL
and	NULL
C57BL/6	NULL
.	NULL

All	NULL
mice	NULL
were	NULL
maintained	NULL
in	NULL
a	NULL
specific-pathogen-free	NULL
environment	NULL
throughout	NULL
the	NULL
study	NULL
.	NULL

PCR	NULL
genotyping	NULL
.	NULL

DNA	NULL
used	NULL
in	NULL
genotyping	NULL
was	NULL
prepared	NULL
from	NULL
toes	NULL
cut	NULL
at	NULL
approximately	NULL
10	NULL
days	NULL
of	NULL
age	NULL
.	NULL

Toe	NULL
tissue	NULL
was	NULL
digested	NULL
at	NULL
50Â°C	NULL
for	NULL
more	NULL
than	NULL
3	NULL
h	NULL
in	NULL
0.1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
25	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
freshly	NULL
added	NULL
proteinase	NULL
K	NULL
(	NULL
0.1	NULL
mg/	NULL
ml	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
purified	NULL
by	NULL
extraction	NULL
with	NULL
phenol	NULL
once	NULL
and	NULL
chloroform	NULL
once	NULL
and	NULL
addition	NULL
of	NULL
2	NULL
volumes	NULL
of	NULL
95	NULL
%	NULL
ethanol	NULL
.	NULL

After	NULL
a	NULL
wash	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
the	NULL
DNA	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
Tris-EDTA	NULL
buffer	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
1	NULL
pl	NULL
of	NULL
DNA	NULL
into	NULL
15	NULL
pl	NULL
of	NULL
the	NULL
reaction	NULL
cocktail	NULL
,	NULL
which	NULL
consisted	NULL
of	NULL
1	NULL
%	NULL
PCR	NULL
buffer	NULL
,	NULL
10	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
1	NULL
mM	NULL
deoxynucleoside	NULL
triphosphate	NULL
,	NULL
0.1	NULL
wM	NULL
cach	NULL
primer	NULL
,	NULL
and	NULL
Tag	NULL
polymerase	NULL
;	NULL
10X	NULL
PCR	NULL
buffer	NULL
contained	NULL
166	NULL
mM	NULL
ammonium	NULL
sulfate	NULL
,	NULL
670	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
67	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
50	NULL
mM	NULL
2-mercapto-ethanol	NULL
,	NULL
and	NULL
67	NULL
M	NULL
EDTA	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
MJ	NULL
thermocycler	NULL
using	NULL
the	NULL
following	NULL
program	NULL
:	NULL
step	NULL
1	NULL
,	NULL
93Â°C	NULL
for	NULL
1.5	NULL
min	NULL
;	NULL
step	NULL
2	NULL
,	NULL
93Â°C	NULL
for	NULL
0.5	NULL
min	NULL
;	NULL
step	NULL
3	NULL
,	NULL
57Â°C	NULL
for	NULL
0.5	NULL
min	NULL
;	NULL
step	NULL
4	NULL
,	NULL
65Â°C	NULL
for	NULL
3	NULL
min	NULL
;	NULL
repetition	NULL
of	NULL
steps	NULL
2	NULL
to	NULL
4	NULL
40	NULL
times	NULL
.	NULL

For	NULL
each	NULL
allele	NULL
,	NULL
three	NULL
PCR	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
simultancous	NULL
amplification	NULL
of	NULL
both	NULL
mutant	NULL
and	NULL
wild-type	NULL
alleles	NULL
.	NULL

Sequences	NULL
of	NULL
PCR	NULL
primers	NULL
used	NULL
in	NULL
genotyping	NULL
and	NULL
the	NULL
results	NULL
expected	NULL
from	NULL
use	NULL
of	NULL
each	NULL
primer	NULL
set	NULL
are	NULL
shown	NULL
in	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Western	NULL
and	NULL
RT-PCR	NULL
analyses	NULL
.	NULL

Western	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
first	NULL
separating	NULL
nuclear	NULL
extracts	NULL
on	NULL
a	NULL
sodium	NULL
dodecyl	NULL
sulfate-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
then	NULL
blotting	NULL
the	NULL
proteins	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Anti-E2A	NULL
polyclonal	NULL
sera	NULL
(	NULL
provided	NULL
by	NULL
T.	NULL
Kadesch	NULL
)	NULL
,	NULL
anti-E2A	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Yae	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
and	NULL
anti-HEB	NULL
polyclonal	NULL
sera	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
relevant	NULL
E	NULL
proteins	NULL
.	NULL

Horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibodies	NULL
were	NULL
used	NULL
in	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reaction	NULL
(	NULL
Am-ersham	NULL
)	NULL
.	NULL

Reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
was	NULL
carried	NULL
out	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
0.1	NULL
pg	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
used	NULL
in	NULL
each	NULL
RT	NULL
reaction	NULL
,	NULL
and	NULL
1/10	NULL
of	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
used	NULL
for	NULL
each	NULL
PCR	NULL
.	NULL

PCR	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
22	NULL
cycles	NULL
with	NULL
elongation	NULL
factor	NULL
1	NULL
alpha	NULL
(	NULL
EF1	NULL
Â«	NULL
)	NULL
primers	NULL
and	NULL
28	NULL
cycles	NULL
with	NULL
all	NULL
of	NULL
the	NULL
E2A	NULL
primers	NULL
.	NULL

Flow	NULL
cytometry	NULL
.	NULL

Bone	NULL
marrow	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
fetal	NULL
liver	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
various	NULL
age	NULL
group	NULL
mice	NULL
and	NULL
used	NULL
immediately	NULL
for	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
.	NULL

Cell	NULL
suspensions	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
a	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
antibody	NULL
and	NULL
a	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
antibody	NULL
plus	NULL
7-amino-actiomycin	NULL
D	NULL
(	NULL
7ZAAD	NULL
)	NULL
.	NULL

Live	NULL
cells	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
for	NULL
simultaneous	NULL
detection	NULL
and	NULL
recording	NULL
of	NULL
FITC	NULL
,	NULL
PE	NULL
,	NULL
and	NULL
7ZAAD	NULL
signals	NULL
.	NULL

Data	NULL
were	NULL
processed	NULL
by	NULL
using	NULL
the	NULL
CellQuest	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

7AAD	NULL
is	NULL
a	NULL
DNA	NULL
dye	NULL
that	NULL
stains	NULL
permeable	NULL
or	NULL
dead	NULL
cells	NULL
(	NULL
Molecular	NULL
Probes	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
7ZAAD	NULL
was	NULL
crucial	NULL
for	NULL
eliminating	NULL
nonspecific	NULL
staining	NULL
of	NULL
antibodies	NULL
to	NULL
dead	NULL
cells	NULL
.	NULL

Anti-mouse	NULL
CD19	NULL
antibody	NULL
was	NULL
provided	NULL
by	NULL
S.	NULL
Sato	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
(	NULL
21	NULL
)	NULL
.	NULL

All	NULL
other	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
,	NULL
Jackson	NULL
Immunology	NULL
,	NULL
and	NULL
Pharmingen	NULL
.	NULL

Irradiation	NULL
and	NULL
stem	NULL
cell	NULL
reconstitution	NULL
.	NULL

C57BL/6	NULL
mice	NULL
congenic	NULL
for	NULL
the	NULL
Ly5A	NULL
allotype	NULL
marker	NULL
were	NULL
purchased	NULL
from	NULL
Jackson	NULL
Laboratories	NULL
.	NULL

Host	NULL
mice	NULL
at	NULL
8	NULL
to	NULL
12	NULL
weeks	NULL
of	NULL
age	NULL
were	NULL
irradiated	NULL
with	NULL
1,100	NULL
rads	NULL
1	NULL
day	NULL
before	NULL
stem	NULL
cell	NULL
transfusion	NULL
and	NULL
maintained	NULL
in	NULL
sterile	NULL
bedding	NULL
and	NULL
antibiotics	NULL
thereafter	NULL
.	NULL

Donor	NULL
cells	NULL
were	NULL
prepared	NULL
from	NULL
either	NULL
frozen	NULL
stocks	NULL
or	NULL
freshly	NULL
isolated	NULL
fetal	NULL
liver	NULL
or	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

From	NULL
0.1	NULL
X	NULL
10Â°	NULL
to	NULL
0.5	NULL
X	NULL
105	NULL
total	NULL
fetal	NULL
liver	NULL
or	NULL
0.5	NULL
X	NULL
10Â°	NULL
to	NULL
2	NULL
X	NULL
10Â°	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
delivered	NULL
to	NULL
the	NULL
host	NULL
in	NULL
0.2	NULL
ml	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
through	NULL
tail	NULL
vein	NULL
injection	NULL
.	NULL

For	NULL
each	NULL
donor	NULL
type	NULL
,	NULL
two	NULL
to	NULL
five	NULL
recipients	NULL
were	NULL
used	NULL
in	NULL
the	NULL
test	NULL
.	NULL

Mice	NULL
were	NULL
bled	NULL
at	NULL
1	NULL
month	NULL
and	NULL
sacrificed	NULL
at	NULL
2	NULL
months	NULL
after	NULL
irradiation	NULL
for	NULL
FACS	NULL
analysis	NULL
.	NULL

RESULTS	NULL
E2A	NULL
alleles	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Table	NULL
3	NULL
lists	NULL
the	NULL
E2A	NULL
alleles	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

EZ2A*Â°	NULL
and	NULL
E2AÂ®*	NULL
are	NULL
two	NULL
independent	NULL
TABLE	NULL
2	NULL
.	NULL

PCR	NULL
primers	NULL
and	NULL
expected	NULL
PCR	NULL
results	NULL
Primer	NULL
set	NULL
Size	NULL
(	NULL
kb	NULL
)	NULL
of	NULL
products	NULL
Allele	NULL
Common	NULL
Mutant	NULL
Wild	NULL
type	NULL
Mutant	NULL
Wild	NULL
type	NULL
E2AÂ®Â°	NULL
YZ-104	NULL
YZ-29	NULL
YZ-164	NULL
2.0	NULL
1.7	NULL
E2A8	NULL
!	NULL

YZ-177	NULL
YZ-24	NULL
E19	NULL
0.9	NULL
1.1	NULL
E2AÂ®bÂ°Â®	NULL
YZ-177	NULL
YZ-24	NULL
E19	NULL
0.9	NULL
1.1	NULL
E12Â°	NULL
YZ-177	NULL
YZ-24	NULL
E19	NULL
1.2	NULL
1.1	NULL
E47Â°=Â°	NULL
YZ-104	NULL
YZ-29	NULL
YZ-164	NULL
2.0	NULL
1.7	NULL
3342	NULL
ZHUANG	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
3	NULL
.	NULL

Summary	NULL
of	NULL
EZ2A	NULL
mutant	NULL
alleles	NULL
Allele	NULL
Mutation	NULL
of	NULL
E2A	NULL
Expression	NULL
Reference	NULL
E2A	NULL
``	NULL
Â®Â°	NULL
-	NULL
Deletion	NULL
E12	NULL
and	NULL
E47	NULL
bHLH	NULL
exons	NULL
Null	NULL
35	NULL
E2AÂ®	NULL
``	NULL
-	NULL
Deletion	NULL
E12	NULL
and	NULL
E47	NULL
bHLH	NULL
exons	NULL
B-Galacto-	NULL
-	NULL
34	NULL
sidase	NULL
E12Â®Â°	NULL
_	NULL
Disruption	NULL
of	NULL
E12	NULL
bHLH	NULL
domain	NULL
E47	NULL
34	NULL
E47Â°~	NULL
-	NULL
Mutation	NULL
in	NULL
E47	NULL
basic	NULL
region	NULL
E47Â°	NULL
``	NULL
,	NULL
E12	NULL
-	NULL
This	NULL
report	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
Deletion	NULL
E12	NULL
and	NULL
E47	NULL
bHLH	NULL
exons	NULL
HEB	NULL
This	NULL
report	NULL
alleles	NULL
with	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
deleted	NULL
from	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
E2A	NULL
``	NULL
*Â°	NULL
allele	NULL
(	NULL
also	NULL
known	NULL
as	NULL
E2A*	NULL
``	NULL
``	NULL
``	NULL
)	NULL
has	NULL
been	NULL
thoroughly	NULL
characterized	NULL
and	NULL
reported	NULL
in	NULL
an	NULL
earlier	NULL
study	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
E2AÂ®	NULL
``	NULL
is	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
EZA	NULL
``	NULL
Â°	NULL
except	NULL
that	NULL
the	NULL
former	NULL
expresses	NULL
a	NULL
-galactosidase	NULL
marker	NULL
driven	NULL
by	NULL
the	NULL
endogenous	NULL
EZ2A	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
both	NULL
alleles	NULL
are	NULL
used	NULL
interchangeably	NULL
as	NULL
E2A-null	NULL
controls	NULL
.	NULL

The	NULL
E12Â®Â°	NULL
allele	NULL
has	NULL
been	NULL
generated	NULL
and	NULL
analyzed	NULL
at	NULL
the	NULL
ES	NULL
cell	NULL
level	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Essentially	NULL
,	NULL
the	NULL
Neo	NULL
coding	NULL
sequence	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
E12	NULL
exon	NULL
to	NULL
produce	NULL
a	NULL
E2A-Neo	NULL
fusion	NULL
protein	NULL
and	NULL
cause	NULL
a	NULL
disruption	NULL
of	NULL
E12	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
strain	NULL
carrying	NULL
this	NULL
mutation	NULL
was	NULL
generated	NULL
and	NULL
characterized	NULL
in	NULL
this	NULL
study	NULL
.	NULL

and	NULL
E2A	NULL
``	NULL
``	NULL
are	NULL
newly	NULL
created	NULL
alleles	NULL
and	NULL
are	NULL
fully	NULL
described	NULL
in	NULL
this	NULL
report	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
E47	NULL
.	NULL

We	NULL
used	NULL
a	NULL
dominant	NULL
negative	NULL
strategy	NULL
to	NULL
investigate	NULL
the	NULL
function	NULL
of	NULL
E47	NULL
and	NULL
its	NULL
potential	NULL
dimerization	NULL
partner	NULL
(	NULL
s	NULL
)	NULL
.	NULL

In	NULL
principle	NULL
,	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
E47	NULL
basic	NULL
region	NULL
disrupts	NULL
the	NULL
DNA	NULL
binding	NULL
but	NULL
not	NULL
the	NULL
protein	NULL
dimerization	NULL
activities	NULL
of	NULL
E47	NULL
.	NULL

Such	NULL
a	NULL
mutation	NULL
not	NULL
only	NULL
abolishes	NULL
the	NULL
function	NULL
of	NULL
E47	NULL
homodimer	NULL
but	NULL
can	NULL
inhibit	NULL
the	NULL
function	NULL
of	NULL
putative	NULL
E47	NULL
heterodimers	NULL
and	NULL
thus	NULL
may	NULL
help	NULL
reveal	NULL
the	NULL
identity	NULL
and	NULL
function	NULL
of	NULL
E47	NULL
dimerization	NULL
partner	NULL
(	NULL
s	NULL
)	NULL
.	NULL

T	NULL
(	NULL
h2	NULL
:	NULL
mutation	NULL
of	NULL
E47	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
E2A	NULL
locus	NULL
by	NULL
gene	NULL
targeting	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
change	NULL
replaced	NULL
two	NULL
conserved	NULL
arginines	NULL
with	NULL
glycines	NULL
in	NULL
the	NULL
protein	NULL
and	NULL
added	NULL
a	NULL
new	NULL
BamHI	NULL
site	NULL
in	NULL
the	NULL
DNA	NULL
.	NULL

Mutation	NULL
at	NULL
the	NULL
identical	NULL
positions	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
a	NULL
true	NULL
dominant	NULL
negative	NULL
mutation	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
mutation	NULL
in	NULL
the	NULL
basic	NULL
region	NULL
,	NULL
the	NULL
gene	NULL
targeting	NULL
construct	NULL
also	NULL
contained	NULL
PGK-Neo	NULL
as	NULL
a	NULL
positive	NULL
selection	NULL
marker	NULL
and	NULL
PGK-TK	NULL
as	NULL
a	NULL
negative	NULL
selection	NULL
marker	NULL
.	NULL

Integration	NULL
of	NULL
PGK-Neo	NULL
into	NULL
the	NULL
E2A	NULL
locus	NULL
was	NULL
determined	NULL
by	NULL
PCR	NULL
analysis	NULL
with	NULL
primers	NULL
YZ-29	NULL
and	NULL
YZ-104	NULL
,	NULL
which	NULL
specifically	NULL
detects	NULL
homologous	NULL
recombination	NULL
at	NULL
the	NULL
3	NULL
'	NULL
region	NULL
.	NULL

The	NULL
positive	NULL
clones	NULL
were	NULL
subsequently	NULL
analyzed	NULL
by	NULL
a	NULL
second	NULL
round	NULL
of	NULL
PCR	NULL
using	NULL
primers	NULL
E21	NULL
and	NULL
YZ-24	NULL
.	NULL

An	NULL
integration	NULL
of	NULL
the	NULL
basic	NULL
region	NULL
mutation	NULL
was	NULL
scored	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
,	NULL
which	NULL
should	NULL
contain	NULL
a	NULL
BamHI	NULL
site	NULL
if	NULL
the	NULL
E47	NULL
basic	NULL
mutation	NULL
is	NULL
retained	NULL
after	NULL
recombination	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
gene	NULL
targeting	NULL
after	NULL
the	NULL
double	NULL
selection	NULL
was	NULL
approximately	NULL
30	NULL
%	NULL
.	NULL

About	NULL
half	NULL
of	NULL
the	NULL
targeted	NULL
clones	NULL
carried	NULL
the	NULL
basic	NULL
mutation	NULL
.	NULL

This	NULL
mutant	NULL
allele	NULL
was	NULL
named	NULL
E47	NULL
``	NULL
.	NULL

The	NULL
E47	NULL
``	NULL
mouse	NULL
strain	NULL
used	NULL
in	NULL
the	NULL
subsequent	NULL
experiments	NULL
was	NULL
derived	NULL
from	NULL
two	NULL
independently	NULL
targeted	NULL
clones	NULL
and	NULL
bred	NULL
in	NULL
the	NULL
129/sv	NULL
and	NULL
C57BL/6	NULL
mixed	NULL
background	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
E2A	NULL
is	NULL
affected	NULL
by	NULL
the	NULL
PGK-Neo	NULL
marker	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
,	NULL
RT-PCR	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
the	NULL
RNA	NULL
levels	NULL
of	NULL
E12	NULL
and	NULL
E47	NULL
in	NULL
E47	NULL
``	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
newly	NULL
introduced	NULL
BamHI	NULL
site	NULL
served	NULL
as	NULL
an	NULL
allelic	NULL
marker	NULL
to	NULL
distinguish	NULL
the	NULL
mutant	NULL
allele	NULL
and	NULL
the	NULL
wild-type	NULL
allele	NULL
in	NULL
E47	NULL
``	NULL
heterozygous	NULL
mice	NULL
.	NULL

Because	NULL
of	NULL
a	NULL
severe	NULL
impairment	NULL
of	NULL
B-cell	NULL
development	NULL
in	NULL
E47	NULL
``	NULL
mice	NULL
,	NULL
thymocyte	NULL
RNA	NULL
were	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Four	NULL
sets	NULL
of	NULL
PCR	NULL
prim-ers	NULL
,	NULL
including	NULL
EF1l	NULL
Â«	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
were	NULL
used	NULL
for	NULL
each	NULL
sample	NULL
.	NULL

This	NULL
semiquantitative	NULL
RT-PCR	NULL
assay	NULL
showed	NULL
that	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

expression	NULL
levels	NULL
of	NULL
E2A	NULL
in	NULL
E47	NULL
``	NULL
homozygous	NULL
mice	NULL
was	NULL
reduced	NULL
to	NULL
about	NULL
60	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
(	NULL
comparing	NULL
E2A	NULL
with	NULL
EFla	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
E47/E12	NULL
splicing	NULL
was	NULL
increased	NULL
approximately	NULL
80	NULL
%	NULL
(	NULL
comparing	NULL
E47	NULL
``	NULL
with	NULL
E12	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
change	NULL
in	NULL
splicing	NULL
is	NULL
still	NULL
under	NULL
investigation	NULL
,	NULL
the	NULL
analysis	NULL
clearly	NULL
demonstrates	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
E12	NULL
transcript	NULL
in	NULL
the	NULL
E47	NULL
``	NULL
mice	NULL
.	NULL

Western	NULL
analysis	NULL
of	NULL
thymus	NULL
extracts	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
total	NULL
EZA	NULL
proteins	NULL
in	NULL
the	NULL
E47	NULL
``	NULL
homozygous	NULL
animals	NULL
is	NULL
approximately	NULL
the	NULL
same	NULL
as	NULL
in	NULL
wild-type	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

Although	NULL
separate	NULL
anti-E2A	NULL
antibodies	NULL
have	NULL
been	NULL
used	NULL
to	NULL
verify	NULL
this	NULL
result	NULL
,	NULL
we	NULL
can	NULL
not	NULL
yet	NULL
distinguish	NULL
E12	NULL
and	NULL
E47	NULL
with	NULL
the	NULL
reagents	NULL
available	NULL
.	NULL

E47	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
survival	NULL
and	NULL
reproduction	NULL
.	NULL

Previous	NULL
studies	NULL
on	NULL
the	NULL
E2A	NULL
knockout	NULL
mice	NULL
have	NULL
shown	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
resulted	NULL
in	NULL
a	NULL
high	NULL
frequency	NULL
of	NULL
postnatal	NULL
death	NULL
and	NULL
deficiency	NULL
in	NULL
B-lineage	NULL
formation	NULL
(	NULL
2	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Subsequent	NULL
studies	NULL
also	NULL
show	NULL
that	NULL
the	NULL
surviving	NULL
EZ2A	NULL
``	NULL
*	NULL
females	NULL
are	NULL
sterile	NULL
,	NULL
while	NULL
males	NULL
are	NULL
fertile	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
E2A*Â°	NULL
mice	NULL
,	NULL
the	NULL
survival	NULL
rates	NULL
of	NULL
E47Â°	NULL
``	NULL
mice	NULL
are	NULL
indistinguishable	NULL
from	NULL
those	NULL
of	NULL
their	NULL
wild-type	NULL
or	NULL
heterozygous	NULL
littermates	NULL
,	NULL
and	NULL
both	NULL
males	NULL
and	NULL
females	NULL
are	NULL
fertile	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
E47	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
postnatal	NULL
survival	NULL
and	NULL
reproduction	NULL
.	NULL

Furthermore	NULL
,	NULL
E47	NULL
``	NULL
may	NULL
play	NULL
a	NULL
dominant	NULL
role	NULL
in	NULL
keeping	NULL
these	NULL
mice	NULL
alive	NULL
and	NULL
fertile	NULL
,	NULL
perhaps	NULL
by	NULL
keeping	NULL
Id	NULL
levels	NULL
in	NULL
check	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
dominant	NULL
negative	NULL
effect	NULL
of	NULL
E47	NULL
``	NULL
can	NULL
not	NULL
be	NULL
completely	NULL
understood	NULL
before	NULL
a	NULL
true	NULL
E47-null	NULL
allele	NULL
is	NULL
available	NULL
(	NULL
experiment	NULL
is	NULL
under	NULL
way	NULL
)	NULL
,	NULL
the	NULL
improved	NULL
viability	NULL
and	NULL
fertility	NULL
already	NULL
makes	NULL
the	NULL
EA47	NULL
``	NULL
``	NULL
mice	NULL
a	NULL
valuable	NULL
strain	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Mice	NULL
without	NULL
normal	NULL
E47	NULL
proteins	NULL
are	NULL
able	NULL
to	NULL
produce	NULL
B	NULL
cells	NULL
in	NULL
neonatal	NULL
but	NULL
not	NULL
adult	NULL
life	NULL
.	NULL

The	NULL
carliest	NULL
committed	NULL
B-lineage	NULL
cells	NULL
are	NULL
characterized	NULL
by	NULL
surface	NULL
expression	NULL
of	NULL
B220	NULL
,	NULL
CD43	NULL
,	NULL
and	NULL
CD19	NULL
antigens	NULL
(	NULL
9	NULL
,	NULL
19	NULL
)	NULL
.	NULL

As	NULL
cells	NULL
mature	NULL
from	NULL
pro-B	NULL
to	NULL
pre-B	NULL
cells	NULL
,	NULL
both	NULL
B220	NULL
and	NULL
CD19	NULL
are	NULL
gradually	NULL
upregulated	NULL
,	NULL
whereas	NULL
CD43	NULL
is	NULL
downregulated	NULL
.	NULL

Mature	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
spleen	NULL
express	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
B220	NULL
and	NULL
CD19	NULL
,	NULL
surface	NULL
IgM	NULL
.	NULL

When	NULL
these	NULL
markers	NULL
are	NULL
used	NULL
to	NULL
analyze	NULL
E47	NULL
``	NULL
neonates	NULL
,	NULL
we	NULL
find	NULL
a	NULL
10-fold	NULL
reduction	NULL
of	NULL
pro-	NULL
and	NULL
pre-B-cell	NULL
numbers	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
more	NULL
than	NULL
a	NULL
20-fold	NULL
reduction	NULL
of	NULL
B-cell	NULL
numbers	NULL
in	NULL
the	NULL
spleen	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
found	NULL
in	NULL
E47Â°	NULL
``	NULL
bone	NULL
marrow	NULL
are	NULL
further	NULL
verified	NULL
by	NULL
PCR	NULL
analysis	NULL
of	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
locus	NULL
,	NULL
which	NULL
detects	NULL
substantial	NULL
D-Jy	NULL
rearrangement	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

No	NULL
B	NULL
cells	NULL
are	NULL
detected	NULL
by	NULL
either	NULL
flow	NULL
cytometry	NULL
or	NULL
PCR	NULL
analysis	NULL
of	NULL
Dy-J	NULL
,	NULL
,	NULL
rearrangements	NULL
in	NULL
the	NULL
same	NULL
age	NULL
group	NULL
of	NULL
E2A-null	NULL
mice	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
normal	NULL
E47	NULL
protein	NULL
,	NULL
E12	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
a	NULL
limited	NULL
but	NULL
definitive	NULL
B-cell	NULL
commitment	NULL
at	NULL
the	NULL
neonatal	NULL
stage	NULL
.	NULL

This	NULL
limited	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
E4	NULL
mice	NULL
,	NULL
however	NULL
,	NULL
is	NULL
observed	NULL
only	NULL
during	NULL
the	NULL
first	NULL
few	NULL
weeks	NULL
of	NULL
postnatal	NULL
life	NULL
.	NULL

Analysis	NULL
of	NULL
2-	NULL
to	NULL
4-month-old-mice	NULL
failed	NULL
to	NULL
detect	NULL
B	NULL
cells	NULL
in	NULL
bone	NULL
marrow	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
peritoneum	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Although	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
CD19~	NULL
cells	NULL
were	NULL
detected	NULL
in	NULL
bone	NULL
marrow	NULL
,	NULL
PCR	NULL
analysis	NULL
did	NULL
not	NULL
show	NULL
any	NULL
Dy-Jy	NULL
rearrangement	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
B220Â°	NULL
CD19~	NULL
cells	NULL
had	NULL
not	NULL
yet	NULL
committed	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
by	NULL
several	NULL
groups	NULL
have	NULL
shown	NULL
that	NULL
bone	NULL
marrow	NULL
B220+	NULL
%	NULL
CD19~	NULL
cells	NULL
contain	NULL
progenitors	NULL
of	NULL
B-lymphoid	NULL
,	NULL
natural	NULL
killer	NULL
,	NULL
and	NULL
other	NULL
undetermined	NULL
cell	NULL
types	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Mice	NULL
without	NULL
E12	NULL
have	NULL
limited	NULL
capacity	NULL
to	NULL
generate	NULL
B	NULL
cells	NULL
.	NULL

Parallel	NULL
to	NULL
the	NULL
analysis	NULL
of	NULL
E47	NULL
``	NULL
mutation	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
an	NULL
E12-specific	NULL
mutation	NULL
,	NULL
which	NULL
had	NULL
been	NULL
generated	NULL
and	NULL
analyzed	NULL
previously	NULL
at	NULL
the	NULL
ES	NULL
cell	NULL
level	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
mutant	NULL
allele	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
the	NULL
Neo	NULL
coding	NULL
region	NULL
into	NULL
the	NULL
bHLH	NULL
domain	NULL
of	NULL
the	NULL
E12-specific	NULL
exon	NULL
.	NULL

This	NULL
mutation	NULL
was	NULL
introduced	NULL
7bm	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
A	NULL
E12	NULL
and	NULL
E47	NULL
exon	NULL
specific	NULL
mutations	NULL
Lkb	NULL
E2A	NULL
--	NULL
Â»	NULL
E12	NULL
B47	NULL
-	NULL
3'stop	NULL
B2A	NULL
wt	NULL
-	NULL
__	NULL
SEX	NULL
]	NULL
Es	NULL
r	NULL
Kpn	NULL
RV	NULL
Xba	NULL
Bam	NULL
<	NULL
-ye-104	NULL
E10	NULL
-	NULL
-	NULL
E	NULL
,	NULL
_	NULL
B	NULL
n	NULL
uy	NULL
r	NULL
Kpn	NULL
Bam	NULL
B	NULL
-	NULL
Â»	NULL
pazbm	NULL
.-	NULL
r	NULL
G	NULL
BH	NULL
[	NULL
pakneol	NULL
a	NULL
Kpn	NULL
-	NULL
>	NULL
<	NULL
-	NULL
>	NULL
Bam	NULL
e-21	NULL
ye24	NULL
-	NULL
y2-29	NULL
B	NULL
Structure	NULL
of	NULL
the	NULL
E47	NULL
specific	NULL
exon	NULL
[	NULL
~	NULL
Thais	NULL
|	NULL
[	NULL
loop	NULL
]	NULL
ERRMANNARERVRV	NULL
_	NULL
B47	NULL
wt	NULL
ERRMANNAREGSGV	NULL
-	NULL
E47bm	NULL
C	NULL
E2A	NULL
Proteins	NULL
in	NULL
Thymus	NULL
RT-PCR	NULL
assay	NULL
of	NULL
E2A	NULL
expression	NULL
in	NULL
E47	NULL
``	NULL
mice	NULL
Ezako	NULL
-	NULL
gazbm	NULL
-	NULL
gqzko	NULL
WT	NULL
4/	NULL
<	NULL
/	NULL
>	NULL
d=	NULL
<	NULL
f	NULL
>	NULL
Jo	NULL
+/	NULL
+l+	NULL
213	NULL
_	NULL
8	NULL
123	NULL
~	NULL
e	NULL
e	NULL
s	NULL
S	NULL
50	NULL
n	NULL
â	NULL
E2A	NULL
wor	NULL
tos	NULL
dag	NULL
)	NULL
=Â©12	NULL
A4	NULL
t4	NULL
E47bm	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
mouse	NULL
E2A	NULL
genomic	NULL
DNA	NULL
(	NULL
from	NULL
KpnI	NULL
to	NULL
BamHI	NULL
)	NULL
was	NULL
used	NULL
in	NULL
the	NULL
gene	NULL
targeting	NULL
experiment	NULL
.	NULL

The	NULL
exons	NULL
contained	NULL
within	NULL
this	NULL
piece	NULL
of	NULL
genomic	NULL
DNA	NULL
are	NULL
shown	NULL
as	NULL
shaded	NULL
boxes	NULL
.	NULL

The	NULL
direction	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
,	NULL
positions	NULL
of	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
polyadenylation	NULL
site	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
structures	NULL
of	NULL
E12	NULL
``	NULL
and	NULL
E47	NULL
``	NULL
alleles	NULL
are	NULL
shown	NULL
according	NULL
to	NULL
the	NULL
scale	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
.	NULL

The	NULL
E12Â®	NULL
``	NULL
allele	NULL
was	NULL
generated	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
promoterless	NULL
neo	NULL
gene	NULL
into	NULL
the	NULL
E12	NULL
exon	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
E47	NULL
``	NULL
allele	NULL
was	NULL
generated	NULL
by	NULL
cointegration	NULL
of	NULL
a	NULL
point	NULL
mutation	NULL
and	NULL
a	NULL
selection	NULL
marker	NULL
into	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

``	NULL
B	NULL
``	NULL
above	NULL
the	NULL
E47	NULL
exon	NULL
of	NULL
the	NULL
E47	NULL
``	NULL
allele	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
basic-region	NULL
mutation	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
BamHI	NULL
site	NULL
.	NULL

A	NULL
PGK-Neo	NULL
cassette	NULL
running	NULL
in	NULL
the	NULL
same	NULL
direction	NULL
as	NULL
the	NULL
EZ2A	NULL
gene	NULL
is	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
Xbel	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

The	NULL
names	NULL
,	NULL
positions	NULL
,	NULL
and	NULL
directions	NULL
of	NULL
PCR	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
constructs	NULL
.	NULL

RV	NULL
,	NULL
EcoRV	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Detailed	NULL
structure	NULL
of	NULL
the	NULL
E47-specific	NULL
exon	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
E47	NULL
wild-type	NULL
and	NULL
E47	NULL
``	NULL
alleles	NULL
are	NULL
shown	NULL
.	NULL

Underlines	NULL
indicate	NULL
amino	NULL
acid	NULL
residues	NULL
that	NULL
are	NULL
conserved	NULL
in	NULL
the	NULL
bHLH	NULL
gene	NULL
family	NULL
,	NULL
and	NULL
boldface	NULL
indicates	NULL
the	NULL
changes	NULL
made	NULL
in	NULL
E47	NULL
``	NULL
.	NULL

(	NULL
C	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
thymocyte	NULL
RNA	NULL
prepared	NULL
from	NULL
E47	NULL
``	NULL
homozygous	NULL
,	NULL
E47	NULL
``	NULL
heterozygous	NULL
,	NULL
and	NULL
wild-type	NULL
animals	NULL
.	NULL

For	NULL
each	NULL
reverse-transcribed	NULL
RNA	NULL
sample	NULL
,	NULL
four	NULL
sets	NULL
of	NULL
PCRs	NULL
were	NULL
performed	NULL
with	NULL
primers	NULL
specific	NULL
to	NULL
(	NULL
i	NULL
)	NULL
EFl	NULL
Â«	NULL
gene	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
E2A	NULL
exons	NULL
common	NULL
to	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
the	NULL
E12-specific	NULL
exon	NULL
,	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
E47-specific	NULL
exon	NULL
.	NULL

To	NULL
differentiate	NULL
E47	NULL
wild-type	NULL
and	NULL
the	NULL
E47	NULL
``	NULL
alleles	NULL
,	NULL
PCR	NULL
product	NULL
generated	NULL
with	NULL
E47	NULL
primers	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
,	NULL
which	NULL
is	NULL
present	NULL
in	NULL
the	NULL
E47	NULL
``	NULL
but	NULL
not	NULL
the	NULL
wild-type	NULL
allele	NULL
(	NULL
in	NULL
lanes	NULL
E47Â°	NULL
``	NULL
+/-	NULL
and	NULL
E47Â°	NULL
``	NULL
-/-	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
repeated	NULL
experiments	NULL
with	NULL
multiple	NULL
individuals	NULL
from	NULL
each	NULL
genotype	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Western	NULL
analysis	NULL
EZA	NULL
THRESHOLD	NULL
CONTROLS	NULL
B-CELL	NULL
LINEAGE	NULL
COMMITMENT	NULL
_	NULL
3343	NULL
recently	NULL
into	NULL
mice	NULL
through	NULL
blastocyst	NULL
injection	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
mice	NULL
were	NULL
subsequently	NULL
bred	NULL
into	NULL
129/sv	NULL
and	NULL
C57BL/6	NULL
backgrounds	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
E47	NULL
in	NULL
the	NULL
E12Â®Â°	NULL
homozygous	NULL
background	NULL
was	NULL
verified	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
(	NULL
34	NULL
)	NULL
and	NULL
by	NULL
Western	NULL
analysis	NULL
in	NULL
this	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
mice	NULL
with	NULL
the	NULL
E47	NULL
``	NULL
mutation	NULL
,	NULL
the	NULL
survival	NULL
rate	NULL
for	NULL
E12*Â°	NULL
mice	NULL
was	NULL
lower	NULL
than	NULL
normal	NULL
but	NULL
significantly	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
E2A	NULL
knockout	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

With	NULL
limited	NULL
breeding	NULL
,	NULL
E12Â®Â°	NULL
males	NULL
were	NULL
found	NULL
to	NULL
be	NULL
normal	NULL
in	NULL
reproduction	NULL
,	NULL
while	NULL
females	NULL
were	NULL
sterile	NULL
.	NULL

At	NULL
the	NULL
neonatal	NULL
stage	NULL
,	NULL
E12Â®Â°	NULL
mice	NULL
showed	NULL
limited	NULL
capacity	NULL
to	NULL
produce	NULL
B	NULL
cells	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
phenotype	NULL
of	NULL
E47	NULL
``	NULL
mice	NULL
,	NULL
a	NULL
small	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
were	NULL
found	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
spleens	NULL
of	NULL
neonatal	NULL
E12	NULL
``	NULL
mice	NULL
.	NULL

The	NULL
bone	NULL
marrow	NULL
B	NULL
cells	NULL
were	NULL
mostly	NULL
B220Â¢	NULL
CD19*	NULL
CD43	NULL
and	NULL
Dy-Jp-rearranged	NULL
pro-B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
splenic	NULL
B	NULL
cells	NULL
were	NULL
B220	NULL
*	NULL
Ig	NULL
M*	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
C	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
E12	NULL
,	NULL
E47	NULL
alone	NULL
is	NULL
capable	NULL
of	NULL
supporting	NULL
B-cell	NULL
commitment	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
produced	NULL
in	NULL
E12	NULL
``	NULL
mice	NULL
is	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
,	NULL
the	NULL
function	NULL
of	NULL
E47	NULL
must	NULL
be	NULL
limited	NULL
.	NULL

A	NULL
noted	NULL
difference	NULL
between	NULL
E12Â®Â°	NULL
and	NULL
E47	NULL
``	NULL
mice	NULL
is	NULL
that	NULL
small	NULL
numbers	NULL
of	NULL
B	NULL
cells	NULL
are	NULL
frequently	NULL
,	NULL
but	NULL
not	NULL
always	NULL
,	NULL
found	NULL
in	NULL
the	NULL
spleens	NULL
of	NULL
adult	NULL
E12Â®Â°	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
is	NULL
about	NULL
1	NULL
to	NULL
5	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
,	NULL
they	NULL
can	NULL
produce	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
serum	NULL
Igs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
2m/E12k	NULL
``	NULL
transheterozygous	NULL
mice	NULL
are	NULL
phenotypically	NULL
similar	NULL
to	NULL
the	NULL
E47	NULL
``	NULL
or	NULL
E12*Â°	NULL
homozygous	NULL
mice	NULL
.	NULL

It	NULL
was	NULL
not	NULL
clear	NULL
why	NULL
E47Â°	NULL
``	NULL
and	NULL
E12Â®Â°	NULL
mice	NULL
had	NULL
only	NULL
limited	NULL
capacity	NULL
to	NULL
produce	NULL
B	NULL
cells	NULL
.	NULL

One	NULL
possible	NULL
interpretation	NULL
is	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
functional	NULL
E12	NULL
or	NULL
E47	NULL
proteins	NULL
in	NULL
E47	NULL
``	NULL
or	NULL
E12*Â°	NULL
mice	NULL
are	NULL
reduced	NULL
below	NULL
a	NULL
threshold	NULL
level	NULL
which	NULL
is	NULL
required	NULL
for	NULL
maintaining	NULL
normal	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
clearly	NULL
showed	NULL
a	NULL
small	NULL
but	NULL
detectable	NULL
reduction	NULL
of	NULL
E12	NULL
and	NULL
E47	NULL
messages	NULL
in	NULL
E47	NULL
``	NULL
and	NULL
E12*Â°	NULL
mice	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
the	NULL
E47	NULL
``	NULL
mice	NULL
,	NULL
the	NULL
level	NULL
of	NULL
functional	NULL
E12	NULL
proteins	NULL
may	NULL
be	NULL
reduced	NULL
even	NULL
further	NULL
by	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
from	NULL
the	NULL
E47	NULL
``	NULL
allele	NULL
,	NULL
but	NULL
we	NULL
can	NULL
not	NULL
say	NULL
if	NULL
this	NULL
suboptimal	NULL
gene	NULL
expression	NULL
is	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
the	NULL
impairment	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
sustained	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
EA7	NULL
``	NULL
``	NULL
and	NULL
E12*Â°	NULL
mice	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
disruption	NULL
of	NULL
synergy	NULL
between	NULL
the	NULL
two	NULL
E	NULL
proteins	NULL
,	NULL
a	NULL
possibility	NULL
suggested	NULL
by	NULL
Bain	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
this	NULL
scenario	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
EA47Â°	NULL
``	NULL
/	NULL
E12*Â°	NULL
transheterozygous	NULL
mice	NULL
.	NULL

The	NULL
transheterozygous	NULL
mice	NULL
were	NULL
born	NULL
and	NULL
lived	NULL
to	NULL
adulthood	NULL
without	NULL
any	NULL
superficial	NULL
difference	NULL
from	NULL
the	NULL
control	NULL
littermates	NULL
.	NULL

Although	NULL
both	NULL
E12	NULL
and	NULL
EA7	NULL
messages	NULL
are	NULL
present	NULL
in	NULL
these	NULL
transheterozygous	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
their	NULL
capacity	NULL
to	NULL
produce	NULL
B-lineage	NULL
cells	NULL
is	NULL
about	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
homozygous	NULL
E12Â®Â°	NULL
or	NULL
E47	NULL
``	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
C	NULL
)	NULL
;	NULL
i.e	NULL
.	NULL

,	NULL
small	NULL
numbers	NULL
of	NULL
B-lineage	NULL
cells	NULL
are	NULL
detected	NULL
in	NULL
neonates	NULL
but	NULL
not	NULL
in	NULL
adults	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
coexpres-sion	NULL
of	NULL
wild-type	NULL
E47	NULL
and	NULL
E12	NULL
proteins	NULL
in	NULL
the	NULL
same	NULL
animal	NULL
is	NULL
sufficient	NULL
to	NULL
initiate	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
the	NULL
neonates	NULL
but	NULL
not	NULL
sufficient	NULL
to	NULL
maintain	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
the	NULL
adult	NULL
.	NULL

Given	NULL
the	NULL
potential	NULL
dominant	NULL
negative	NULL
effect	NULL
from	NULL
the	NULL
E47	NULL
``	NULL
allele	NULL
,	NULL
we	NULL
can	NULL
not	NULL
say	NULL
how	NULL
much	NULL
of	NULL
the	NULL
functional	NULL
E12	NULL
and	NULL
E47	NULL
proteins	NULL
are	NULL
available	NULL
to	NULL
support	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
the	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
the	NULL
phenotypic	NULL
similarity	NULL
among	NULL
E47	NULL
``	NULL
``	NULL
ho	NULL
of	NULL
E2A	NULL
proteins	NULL
in	NULL
the	NULL
thymus	NULL
isolated	NULL
from	NULL
the	NULL
wild-type	NULL
,	NULL
E2A*Â®	NULL
,	NULL
E47	NULL
``	NULL
,	NULL
and	NULL
E12**	NULL
mice	NULL
.	NULL

Genotypes	NULL
of	NULL
the	NULL
samples	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Size	NULL
markers	NULL
in	NULL
kilodaltons	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
left	NULL
,	NULL
and	NULL
positions	NULL
of	NULL
the	NULL
full-length	NULL
E2A	NULL
proteins	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
right	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B-cell	NULL
development	NULL
in	NULL
10	NULL
-20	NULL
day	NULL
old	NULL
pups	NULL
E12ko	NULL
E47bm	NULL
E12kog47bm	NULL
_	NULL
0.4	NULL
Bone	NULL
Marrow	NULL
Spleen	NULL
B220	NULL
FITC	NULL
3344	NULL
ZHUANG	NULL
ET	NULL
AL	NULL
.	NULL

E2Ako	NULL
a	NULL
A	NULL
U	NULL
&	NULL
f	NULL
a	NULL
W	NULL
bs	NULL
S	NULL
B	NULL
B-cell	NULL
development	NULL
in	NULL
adult	NULL
mice	NULL
C	NULL
g	NULL
_	NULL
Control	NULL
E47bm	NULL
E47bm/g12ko	NULL
>	NULL
50	NULL
2	NULL
Â®	NULL
Fur	NULL
3	NULL
o	NULL
a	NULL
A	NULL
-	NULL
Â»	NULL
40	NULL
u-	NULL
3	NULL
J	NULL
g	NULL
E	NULL
AA	NULL
p	NULL
SD	NULL
Â®	NULL
D	NULL
a	NULL
--	NULL
E	NULL
cle	NULL
s	NULL
7	NULL
.	NULL

B	NULL
aA	NULL
s	NULL
33	NULL
[	NULL
=	NULL
]	NULL
3	NULL
O	NULL
A	NULL
5	NULL
C	NULL
A	NULL
9.2	NULL
:	NULL
E	NULL
~	NULL
tof	NULL
aot	NULL
__	NULL
go	NULL
B220	NULL
FITC	NULL
A	NULL
limited	NULL
B-lymphopoiesis	NULL
in	NULL
E47Â°	NULL
``	NULL
and	NULL
E12*Â°	NULL
mice	NULL
wt	NULL
E47bm	NULL
E12ko	NULL
E47bm/E12ko	NULL
n=4	NULL
COMS	NULL
n=9	NULL
n=10	NULL
n=4	NULL
-_-	NULL
a	NULL
-s	NULL
splen	NULL
(	NULL
adult	NULL
)	NULL
bone	NULL
marrow	NULL
(	NULL
adult	NULL
)	NULL
bone	NULL
marrow	NULL
(	NULL
pup	NULL
)	NULL
spleen	NULL
(	NULL
pup	NULL
)	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Three-channel	NULL
FACS	NULL
analysis	NULL
of	NULL
live	NULL
bone	NULL
marrow	NULL
(	NULL
top	NULL
two	NULL
panels	NULL
)	NULL
and	NULL
spleen	NULL
B	NULL
cells	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
prepared	NULL
from	NULL
10-	NULL
to	NULL
20-day-old	NULL
pups	NULL
carrying	NULL
various	NULL
E2A	NULL
mutations	NULL
.	NULL

The	NULL
genotype	NULL
of	NULL
each	NULL
animal	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
vertical	NULL
panel	NULL
,	NULL
which	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
FACS	NULL
analyses	NULL
of	NULL
the	NULL
same	NULL
animal	NULL
.	NULL

B220-FITC	NULL
and	NULL
7AAD	NULL
were	NULL
included	NULL
in	NULL
all	NULL
the	NULL
stainings	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD19-PE	NULL
or	NULL
CD43-PE	NULL
was	NULL
used	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
samples	NULL
,	NULL
and	NULL
Ig	NULL
M-PE	NULL
was	NULL
used	NULL
in	NULL
the	NULL
spleen	NULL
samples	NULL
.	NULL

The	NULL
variation	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
CD19-PE	NULL
staining	NULL
is	NULL
due	NULL
to	NULL
batch	NULL
difference	NULL
in	NULL
the	NULL
antibody	NULL
used	NULL
.	NULL

To	NULL
enrich	NULL
lymphocytes	NULL
and	NULL
to	NULL
exclude	NULL
dead	NULL
cells	NULL
in	NULL
the	NULL
analysis	NULL
,	NULL
size	NULL
gate	NULL
and	NULL
7AAD	NULL
gate	NULL
were	NULL
used	NULL
for	NULL
all	NULL
the	NULL
dot	NULL
plots	NULL
displayed	NULL
.	NULL

The	NULL
relative	NULL
percentages	NULL
of	NULL
pro-B	NULL
,	NULL
pre-B	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
in	NULL
total	NULL
live	NULL
cells	NULL
are	NULL
given	NULL
in	NULL
each	NULL
plot	NULL
.	NULL

FACS	NULL
analysis	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
adult	NULL
mice	NULL
.	NULL

Wild-type	NULL
control	NULL
,	NULL
E47	NULL
``	NULL
homozygous	NULL
and	NULL
EA47	NULL
``	NULL
/E12*	NULL
transheterozygous	NULL
mice	NULL
were	NULL
analyzed	NULL
with	NULL
B220	NULL
and	NULL
7AAD	NULL
plus	NULL
CD19	NULL
for	NULL
bone	NULL
marrow	NULL
,	NULL
IgM	NULL
for	NULL
spleen	NULL
,	NULL
and	NULL
CDS	NULL
for	NULL
peritoneum	NULL
samples	NULL
.	NULL

Presentation	NULL
of	NULL
data	NULL
is	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Average	NULL
B-cell	NULL
numbers	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
total	NULL
nucleated	NULL
bone	NULL
marrow	NULL
or	NULL
spleen	NULL
populations	NULL
.	NULL

Both	NULL
sample	NULL
size	NULL
and	NULL
standard	NULL
deviation	NULL
are	NULL
shown	NULL
with	NULL
each	NULL
data	NULL
bar	NULL
.	NULL

Four	NULL
genotype	NULL
groups	NULL
of	NULL
animals	NULL
,	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
,	NULL
E47	NULL
``	NULL
homozygous	NULL
,	NULL
E12	NULL
``	NULL
homozygous	NULL
,	NULL
and	NULL
EA47	NULL
``	NULL
``	NULL
/E12*Â°	NULL
transheterozygous	NULL
,	NULL
are	NULL
included	NULL
.	NULL

Pup	NULL
is	NULL
equivalent	NULL
to	NULL
10	NULL
to	NULL
20	NULL
days	NULL
old	NULL
;	NULL
adult	NULL
is	NULL
more	NULL
than	NULL
2	NULL
months	NULL
old	NULL
.	NULL

mozygous	NULL
,	NULL
E12Â®Â°	NULL
homozygous	NULL
,	NULL
and	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
transheterozygous	NULL
mice	NULL
indicates	NULL
an	NULL
underlying	NULL
common	NULL
defect	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

Stem	NULL
cell	NULL
transfusion	NULL
confirms	NULL
a	NULL
B-cell-specific	NULL
role	NULL
for	NULL
E12	NULL
and	NULL
E47	NULL
.	NULL

E12Â°	NULL
and	NULL
E47	NULL
``	NULL
mice	NULL
have	NULL
a	NULL
limited	NULL
capacity	NULL
to	NULL
generate	NULL
B-lineage	NULL
cells	NULL
.	NULL

This	NULL
suppression	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
could	NULL
be	NULL
due	NULL
to	NULL
an	NULL
intrinsic	NULL
defect	NULL
within	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
a	NULL
nonsupportive	NULL
stromal	NULL
environment	NULL
,	NULL
or	NULL
both	NULL
.	NULL

To	NULL
test	NULL
this	NULL
pos-	NULL
sibility	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
stem	NULL
cell	NULL
transfusion	NULL
test	NULL
.	NULL

HSC	NULL
from	NULL
either	NULL
the	NULL
fetal	NULL
livers	NULL
of	NULL
E12*Â°	NULL
mice	NULL
or	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
EA7	NULL
``	NULL
``	NULL
neonates	NULL
were	NULL
used	NULL
as	NULL
donors	NULL
to	NULL
complement	NULL
lethally	NULL
irradiated	NULL
wild-type	NULL
hosts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
HSC	NULL
from	NULL
both	NULL
E12*Â°	NULL
and	NULL
E47	NULL
``	NULL
mice	NULL
are	NULL
capable	NULL
of	NULL
providing	NULL
radioprotection	NULL
and	NULL
giving	NULL
rise	NULL
to	NULL
T-lymphoid	NULL
,	NULL
myeloid	NULL
cells	NULL
but	NULL
not	NULL
B	NULL
cells	NULL
.	NULL

Meanwhile	NULL
,	NULL
a	NULL
normal	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
generated	NULL
when	NULL
wild-type	NULL
fetal	NULL
liver	NULL
or	NULL
bone	NULL
marrow	NULL
is	NULL
used	NULL
as	NULL
the	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
neonate	NULL
Mud	NULL
5	NULL
|	NULL
f	NULL
i	NULL
-J2	NULL
-J3	NULL
â	NULL
Â«	NULL
ae	NULL
+	NULL
I	NULL
-	NULL
Ja	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

PCR	NULL
analysis	NULL
of	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
D-J	NULL
rearrangements	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
purified	NULL
from	NULL
bone	NULL
marrow	NULL
of	NULL
either	NULL
10-	NULL
to	NULL
20-day-old	NULL
neonates	NULL
or	NULL
2-month-old	NULL
adults	NULL
.	NULL

PCR	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
J4-specific	NULL
primer	NULL
(	NULL
24	NULL
)	NULL
and	NULL
a	NULL
D-segment-specific	NULL
primer	NULL
that	NULL
hybridizes	NULL
to	NULL
the	NULL
upstream	NULL
sequence	NULL
of	NULL
most	NULL
D	NULL
segments	NULL
(	NULL
8	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
representing	NULL
specific	NULL
D-J	NULL
rearrangements	NULL
were	NULL
revealed	NULL
by	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
that	NULL
hybridizes	NULL
to	NULL
the	NULL
internal	NULL
side	NULL
of	NULL
the	NULL
J4	NULL
primer	NULL
.	NULL

The	NULL
running	NULL
positions	NULL
of	NULL
DNA	NULL
size	NULL
markers	NULL
and	NULL
J	NULL
segments	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
and	NULL
right	NULL
side	NULL
,	NULL
respectively	NULL
.	NULL

WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

m	NULL
-M	NULL
&	NULL
.	NULL

~	NULL
)	NULL
~a	NULL
1	NULL
kb	NULL
ladder	NULL
wT	NULL
E47Â°M	NULL
(	NULL
-/	NULL
)	NULL
E47Â°M	NULL
(	NULL
-/	NULL
.	NULL
)	NULL

E12k0	NULL
(	NULL
/	NULL
)	NULL
E12k9	NULL
(	NULL
/	NULL
)	NULL
E47bm	NULL
(	NULL
-/-	NULL
)	NULL
donor	NULL
.	NULL

This	NULL
result	NULL
confirms	NULL
the	NULL
transfusion	NULL
test	NULL
with	NULL
the	NULL
E2A-null	NULL
cells	NULL
as	NULL
donors	NULL
(	NULL
36	NULL
)	NULL
and	NULL
indicates	NULL
that	NULL
disruption	NULL
of	NULL
either	NULL
E12	NULL
or	NULL
E47	NULL
specifically	NULL
limits	NULL
the	NULL
potential	NULL
of	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
B-lineage	NULL
cells	NULL
.	NULL

Adoptive	NULL
transfer	NULL
in	NULL
the	NULL
reverse	NULL
direction	NULL
has	NULL
been	NULL
impossible	NULL
in	NULL
the	NULL
past	NULL
because	NULL
of	NULL
the	NULL
lethality	NULL
of	NULL
E2A	NULL
knockout	NULL
.	NULL

The	NULL
EA7	NULL
``	NULL
*	NULL
``	NULL
mice	NULL
generated	NULL
in	NULL
this	NULL
study	NULL
provided	NULL
excellent	NULL
hosts	NULL
for	NULL
transfusion	NULL
tests	NULL
.	NULL

We	NULL
now	NULL
know	NULL
that	NULL
wild-type	NULL
HSC	NULL
can	NULL
provide	NULL
complete	NULL
radioprotection	NULL
and	NULL
give	NULL
rise	NULL
to	NULL
B-lineage	NULL
cells	NULL
in	NULL
the	NULL
lethally	NULL
irradiated	NULL
E47	NULL
``	NULL
hosts	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
demonstrating	NULL
a	NULL
permissive	NULL
stromal	NULL
environment	NULL
for	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
EA7	NULL
``	NULL
mice	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
adult	NULL
EA7	NULL
``	NULL
``	NULL
mice	NULL
is	NULL
almost	NULL
exclusively	NULL
due	NULL
to	NULL
a	NULL
B-lineage	NULL
autonomous	NULL
defect	NULL
.	NULL

Replacement	NULL
of	NULL
E2A	NULL
with	NULL
a	NULL
human	NULL
HEB	NULL
cDNA	NULL
.	NULL

Analyses	NULL
of	NULL
EA7	NULL
``	NULL
``	NULL
and	NULL
E12*Â°	NULL
mice	NULL
suggest	NULL
that	NULL
the	NULL
B-cell-specific	NULL
function	NULL
of	NULL
E2A	NULL
has	NULL
at	NULL
least	NULL
two	NULL
features	NULL
:	NULL
it	NULL
requires	NULL
a	NULL
structural	NULL
domain	NULL
shared	NULL
by	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
and	NULL
it	NULL
demands	NULL
a	NULL
minimal	NULL
dosage	NULL
of	NULL
functional	NULL
EZ2A	NULL
proteins	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
these	NULL
phenomena	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
functions	NULL
of	NULL
E2A	NULL
proteins	NULL
and	NULL
HEB	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
encoded	NULL
by	NULL
a	NULL
separate	NULL
E-protein	NULL
gene	NULL
.	NULL

The	NULL
sequence	NULL
similarity	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
between	NULL
HEB	NULL
and	NULL
E2A	NULL
is	NULL
82	NULL
%	NULL
(	NULL
for	NULL
E47	NULL
)	NULL
and	NULL
89	NULL
%	NULL
(	NULL
for	NULL
E12	NULL
)	NULL
within	NULL
the	NULL
bHLH	NULL
domain	NULL
and	NULL
is	NULL
significantly	NULL
lower	NULL
outside	NULL
the	NULL
bHLH	NULL
domain	NULL
(	NULL
11	NULL
)	NULL
.	NULL

We	NULL
had	NULL
shown	NULL
previously	NULL
by	NULL
gene	NULL
disruption	NULL
that	NULL
HEB	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
B-cell	NULL
commitment	NULL
and	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
mice	NULL
compound-heterozygous	NULL
for	NULL
E2A	NULL
and	NULL
HEB	NULL
disruption	NULL
have	NULL
reduced	NULL
capacity	NULL
for	NULL
producing	NULL
pro-B	NULL
cells	NULL
in	NULL
fetal	NULL
liver	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
HEB	NULL
in	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

To	NULL
allow	NULL
a	NULL
direct	NULL
comparison	NULL
of	NULL
the	NULL
function	NULL
of	NULL
EZA	NULL
and	NULL
HEB	NULL
in	NULL
the	NULL
context	NULL
of	NULL
B-cell	NULL
development	NULL
,	NULL
we	NULL
introduced	NULL
an	NULL
HEB	NULL
cDNA	NULL
into	NULL
the	NULL
E2A	NULL
locus	NULL
through	NULL
gene	NULL
targeting	NULL
.	NULL

A	NULL
full-length	NULL
human	NULL
HEB	NULL
cDNA	NULL
driven	NULL
by	NULL
an	NULL
IRES	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
was	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
.	NULL

Selection	NULL
of	NULL
targeting	NULL
events	NULL
was	NULL
achieved	NULL
by	NULL
adding	NULL
the	NULL
neo	NULL
gene	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
EZA	NULL
coding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Gene-targeting	NULL
events	NULL
with	NULL
this	NULL
HEB	NULL
insertional	NULL
construct	NULL
were	NULL
ob	NULL
E2A	NULL
THRESHOLD	NULL
CONTROLS	NULL
B-CELL	NULL
LINEAGE	NULL
COMMITMENT	NULL
_	NULL
3345	NULL
tained	NULL
at	NULL
a	NULL
frequency	NULL
of	NULL
65	NULL
%	NULL
after	NULL
G418	NULL
selection	NULL
,	NULL
demonstrating	NULL
the	NULL
selection	NULL
efficiency	NULL
of	NULL
the	NULL
construct	NULL
.	NULL

The	NULL
validity	NULL
of	NULL
this	NULL
targeting	NULL
strategy	NULL
for	NULL
expression	NULL
of	NULL
an	NULL
inserted	NULL
cDNA	NULL
under	NULL
the	NULL
endogenous	NULL
E2A	NULL
promoter	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
the	NULL
construction	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
E2A*	NULL
allele	NULL
,	NULL
in	NULL
which	NULL
inactivation	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
is	NULL
concomitant	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
B-galactosidase	NULL
marker	NULL
by	NULL
the	NULL
endogenous	NULL
EZA	NULL
promoter	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

We	NULL
have	NULL
since	NULL
shown	NULL
that	NULL
this	NULL
E2AÂ®*	NULL
``	NULL
allele	NULL
drives	NULL
B-galactosidase	NULL
expression	NULL
in	NULL
a	NULL
broad	NULL
pattern	NULL
throughout	NULL
em-bryogenesis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mice	NULL
carrying	NULL
the	NULL
newly	NULL
created	NULL
gene	NULL
replacement	NULL
allele	NULL
,	NULL
named	NULL
EZ2A	NULL
``	NULL
``	NULL
,	NULL
were	NULL
tested	NULL
by	NULL
Western	NULL
analysis	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
HEB	NULL
protein	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
spleen	NULL
and	NULL
thymus	NULL
were	NULL
probed	NULL
with	NULL
anti-HEB	NULL
antibodies	NULL
,	NULL
which	NULL
cross-react	NULL
with	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
HEB	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
level	NULL
of	NULL
the	NULL
endogenous	NULL
HEB	NULL
proteins	NULL
is	NULL
low	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
high	NULL
in	NULL
the	NULL
thymus	NULL
in	NULL
wild-type	NULL
animals	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
EZ2A	NULL
gene	NULL
with	NULL
the	NULL
HEB	NULL
cDNA	NULL
leads	NULL
to	NULL
a	NULL
moderate	NULL
increase	NULL
of	NULL
HEB	NULL
proteins	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
a	NULL
dramatic	NULL
increase	NULL
of	NULL
HEB	NULL
proteins	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
E2A	NULL
proteins	NULL
was	NULL
verified	NULL
by	NULL
anti-E2A	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
no	NULL
increase	NULL
of	NULL
HEB	NULL
expression	NULL
is	NULL
seen	NULL
in	NULL
E2A*Â°	NULL
heterozygous	NULL
mice	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
increased	NULL
HEB	NULL
proteins	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
HEB	NULL
cDNA	NULL
rather	NULL
than	NULL
from	NULL
upregulation	NULL
of	NULL
the	NULL
endogenous	NULL
mouse	NULL
HEB	NULL
gene	NULL
.	NULL

A	NULL
gel	NULL
shift	NULL
assay	NULL
with	NULL
the	NULL
Ig	NULL
E5	NULL
enhancer	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
the	NULL
activity	NULL
of	NULL
HEB	NULL
proteins	NULL
produced	NULL
from	NULL
the	NULL
EZ2A	NULL
locus	NULL
.	NULL

It	NULL
has	NULL
been	NULL
well	NULL
documented	NULL
that	NULL
wE5	NULL
is	NULL
specifically	NULL
recognized	NULL
by	NULL
EZA-containing	NULL
protein	NULL
dimers	NULL
in	NULL
B-cell	NULL
extracts	NULL
(	NULL
1	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
the	NULL
E2A-uE5	NULL
complex	NULL
can	NULL
be	NULL
seen	NULL
as	NULL
a	NULL
supershift	NULL
with	NULL
anti-EZ2A	NULL
antibody	NULL
in	NULL
wild-type	NULL
splenocytes	NULL
(	NULL
Jane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
in	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
~	NULL
``	NULL
~	NULL
splenocytes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
HEB-pmE5	NULL
complex	NULL
is	NULL
seen	NULL
as	NULL
a	NULL
supershift	NULL
with	NULL
anti-HEB	NULL
antibody	NULL
in	NULL
the	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
splenocytes	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
but	NULL
not	NULL
in	NULL
the	NULL
wild-type	NULL
splenocytes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
E2A-dependent	NULL
E5	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
replaced	NULL
by	NULL
HEB	NULL
.	NULL

However	NULL
,	NULL
HEB	NULL
may	NULL
have	NULL
a	NULL
lower	NULL
affinity	NULL
for	NULL
the	NULL
wE5	NULL
site	NULL
than	NULL
E2A	NULL
does	NULL
in	NULL
the	NULL
splenocytes	NULL
since	NULL
the	NULL
HEB-pE5	NULL
complex	NULL
can	NULL
only	NULL
be	NULL
seen	NULL
as	NULL
a	NULL
supershift	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
HEB	NULL
proteins	NULL
was	NULL
also	NULL
tested	NULL
in	NULL
thymocyte	NULL
extracts	NULL
,	NULL
where	NULL
a	NULL
replacement	NULL
of	NULL
the	NULL
HEB-EZA	NULL
heterodimers	NULL
(	NULL
lane	NULL
7	NULL
to	NULL
9	NULL
)	NULL
by	NULL
HEB	NULL
homodimers	NULL
(	NULL
lane	NULL
10	NULL
,	NULL
11	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
E2A	NULL
``	NULL
Â®	NULL
``	NULL
mice	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
an	NULL
observation	NULL
made	NULL
by	NULL
Sawada	NULL
and	NULL
Littman	NULL
(	NULL
22	NULL
)	NULL
that	NULL
E	NULL
proteins	NULL
in	NULL
wild-type	NULL
T	NULL
cells	NULL
were	NULL
heterodimers	NULL
between	NULL
E2A	NULL
and	NULL
HEB	NULL
.	NULL

A	NULL
copy	NULL
number-dependent	NULL
rescue	NULL
of	NULL
B-cell	NULL
development	NULL
by	NULL
E24	NULL
``	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
in	NULL
B	NULL
lymphopoiesis	NULL
was	NULL
tested	NULL
by	NULL
analyzing	NULL
B-cell	NULL
contents	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
spleens	NULL
of	NULL
preweaning-age	NULL
animals	NULL
,	NULL
a	NULL
stage	NULL
when	NULL
B	NULL
lymphopoiesis	NULL
is	NULL
sensitive	NULL
to	NULL
the	NULL
E2A	NULL
protein	NULL
dosage	NULL
.	NULL

Even	NULL
in	NULL
heterozygous	NULL
animals	NULL
,	NULL
a	NULL
contribution	NULL
to	NULL
B-cell	NULL
development	NULL
from	NULL
the	NULL
EZ2A	NULL
``	NULL
``	NULL
allele	NULL
can	NULL
be	NULL
readily	NULL
seen	NULL
by	NULL
comparison	NULL
of	NULL
E2A	NULL
``	NULL
``	NULL
heterozygous	NULL
mice	NULL
with	NULL
E2A*Â°	NULL
heterozygous	NULL
mice	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
E2A	NULL
``	NULL
``	NULL
``	NULL
heterozygous	NULL
mice	NULL
generate	NULL
twice	NULL
as	NULL
many	NULL
B	NULL
cells	NULL
as	NULL
E2A*Â°	NULL
heterozygous	NULL
mice	NULL
do	NULL
.	NULL

The	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
found	NULL
in	NULL
E2A	NULL
``	NULL
Â®	NULL
``	NULL
heterozygous	NULL
mice	NULL
is	NULL
no	NULL
less	NULL
,	NULL
and	NULL
perhaps	NULL
slightly	NULL
high-er	NULL
,	NULL
than	NULL
the	NULL
B-cell	NULL
number	NULL
in	NULL
the	NULL
wild-type	NULL
controls	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
EZ2A	NULL
``	NULL
Â®	NULL
``	NULL
activity	NULL
on	NULL
the	NULL
E2A-null	NULL
background	NULL
by	NULL
crossing	NULL
E2A	NULL
``	NULL
``	NULL
heterozygous	NULL
mice	NULL
with	NULL
E2A*Â°	NULL
heterozygous	NULL
mice	NULL
.	NULL

Genotyping	NULL
analysis	NULL
of	NULL
1-	NULL
to	NULL
3-week-old	NULL
pups	NULL
showed	NULL
that	NULL
the	NULL
survival	NULL
rate	NULL
of	NULL
transheterozygous	NULL
offspring	NULL
is	NULL
slightly	NULL
lower	NULL
than	NULL
expected	NULL
(	NULL
16	NULL
wild	NULL
type	NULL
,	NULL
36	NULL
heterozygous	NULL
,	NULL
and	NULL
11	NULL
trans-heterozygous	NULL
)	NULL
but	NULL
significantly	NULL
improved	NULL
from	NULL
age-matched	NULL
E2A-null	NULL
homozygous	NULL
mice	NULL
(	NULL
33	NULL
)	NULL
.	NULL

FACS	NULL
analysis	NULL
with	NULL
B-cell	NULL
lineage	NULL
markers	NULL
showed	NULL
that	NULL
the	NULL
E2A	NULL
``	NULL
Â®	NULL
``	NULL
/E2A*Â°	NULL
mice	NULL
generate	NULL
extremely	NULL
low	NULL
numbers	NULL
of	NULL
pro-B	NULL
cells	NULL
(	NULL
B220	NULL
+	NULL
CD43*	NULL
CD19*	NULL
)	NULL
3346	NULL
ZHUANG	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
BM	NULL
(	NULL
wt	NULL
)	NULL
BM	NULL
(	NULL
EATPÂ®	NULL
!	NULL
)	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FL	NULL
(	NULL
wt	NULL
)	NULL
FL	NULL
(	NULL
E12Â®	NULL
)	NULL
)	NULL
3	NULL
0.2	NULL
00	NULL
;	NULL
.	NULL

-	NULL
0.5	NULL
0.1	NULL
IgM	NULL
CD5	NULL
Macl	NULL
1	NULL
f	NULL
,	NULL
(	NULL
oH	NULL
10	NULL
%	NULL
aao	NULL
ao	NULL
)	NULL
aot	NULL
aot	NULL
4o	NULL
%	NULL
ao	NULL
``	NULL
ao	NULL
``	NULL
10	NULL
%	NULL
ao	NULL
aot	NULL
ao	NULL
``	NULL
ao	NULL
)	NULL
aot	NULL
I	NULL
CD45.2	NULL
(	NULL
donor	NULL
marker	NULL
)	NULL
Us	NULL
B220	NULL
Macl	NULL
``	NULL
2	NULL
``	NULL
7C	NULL
m	NULL
J	NULL
Â»	NULL
reptrber	NULL
rr	NULL
:	NULL
10	NULL
%	NULL
40Â°	NULL
40	NULL
``	NULL
40	NULL
â¬CD45.2	NULL
(	NULL
host	NULL
marker	NULL
)	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
neonatal	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
one	NULL
copy	NULL
of	NULL
E2A	NULL
``	NULL
``	NULL
is	NULL
insufficient	NULL
to	NULL
completely	NULL
rescue	NULL
EZ2A-null	NULL
defects	NULL
.	NULL

E2A	NULL
``	NULL
Â®	NULL
``	NULL
homozygous	NULL
mice	NULL
are	NULL
recovered	NULL
with	NULL
expected	NULL
frequency	NULL
(	NULL
14	NULL
+/+	NULL
,	NULL
35	NULL
+/-	NULL
,	NULL
and	NULL
22	NULL
-/-	NULL
)	NULL
from	NULL
E2A	NULL
``	NULL
``	NULL
heterozygous	NULL
intercross	NULL
.	NULL

These	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
homozygous	NULL
mice	NULL
are	NULL
superficially	NULL
indistinguishable	NULL
from	NULL
their	NULL
wild-type	NULL
and	NULL
heterozygous	NULL
littermates	NULL
,	NULL
indicating	NULL
a	NULL
general	NULL
rescue	NULL
of	NULL
E2A-null	NULL
defects	NULL
by	NULL
two	NULL
copies	NULL
of	NULL
EZA	NULL
``	NULL
``	NULL
.	NULL

Further	NULL
,	NULL
interbreeding	NULL
of	NULL
EZ2A	NULL
``	NULL
*	NULL
``	NULL
homozygous	NULL
mice	NULL
has	NULL
produced	NULL
healthy	NULL
offspring	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
E2A	NULL
``	NULL
Â°	NULL
``	NULL
/EZA*Â°	NULL
transheterozygous	NULL
mice	NULL
,	NULL
a	NULL
substantial	NULL
number	NULL
of	NULL
B-lineage	NULL
cells	NULL
,	NULL
including	NULL
pro-	NULL
and	NULL
pre-B	NULL
cells	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
were	NULL
detected	NULL
in	NULL
bone	NULL
marrow	NULL
and	NULL
spleen	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
a	NULL
functional	NULL
replacement	NULL
of	NULL
E2A	NULL
by	NULL
HEB	NULL
in	NULL
both	NULL
the	NULL
commitment	NULL
and	NULL
maturation	NULL
processes	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

The	NULL
number	NULL
of	NULL
bone	NULL
marrow	NULL
B	NULL
cells	NULL
in	NULL
these	NULL
E2A	NULL
``	NULL
``	NULL
mice	NULL
is	NULL
about	NULL
40	NULL
%	NULL
of	NULL
the	NULL
number	NULL
in	NULL
the	NULL
wild	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
FACS	NULL
analysis	NULL
of	NULL
spleen	NULL
samples	NULL
from	NULL
stem	NULL
cell	NULL
transfusion	NULL
experiments	NULL
.	NULL

Sources	NULL
of	NULL
donor	NULL
stem	NULL
cells	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
(	NULL
BM	NULL
,	NULL
bone	NULL
marrow	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
FL	NULL
,	NULL
fetal	NULL
liver	NULL
)	NULL
.	NULL

Each	NULL
vertical	NULL
panel	NULL
represents	NULL
separate	NULL
FACS	NULL
analysis	NULL
for	NULL
B	NULL
cells	NULL
(	NULL
IgM	NULL
)	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
CD5	NULL
)	NULL
,	NULL
and	NULL
myeloid	NULL
cells	NULL
(	NULL
Mac1	NULL
)	NULL
from	NULL
the	NULL
same	NULL
splenic	NULL
sample	NULL
.	NULL

CD45.2	NULL
(	NULL
Pharmingen	NULL
)	NULL
is	NULL
an	NULL
allotype	NULL
marker	NULL
that	NULL
is	NULL
present	NULL
on	NULL
the	NULL
donor	NULL
cells	NULL
and	NULL
absent	NULL
on	NULL
host	NULL
cells	NULL
.	NULL

To	NULL
eliminate	NULL
nonspecific	NULL
staining	NULL
and	NULL
dead	NULL
cells	NULL
,	NULL
7ZAAD	NULL
was	NULL
also	NULL
included	NULL
in	NULL
all	NULL
the	NULL
staining	NULL
reactions	NULL
.	NULL

Percentages	NULL
of	NULL
cells	NULL
given	NULL
in	NULL
the	NULL
quadrants	NULL
are	NULL
calculated	NULL
based	NULL
on	NULL
total	NULL
live	NULL
cells	NULL
rather	NULL
than	NULL
the	NULL
size-gated	NULL
population	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
transfusion	NULL
tests	NULL
for	NULL
each	NULL
donor	NULL
type	NULL
.	NULL

(	NULL
B	NULL
)	NULL
FACS	NULL
analysis	NULL
of	NULL
an	NULL
E47	NULL
``	NULL
mouse	NULL
(	NULL
representative	NULL
of	NULL
three	NULL
mice	NULL
)	NULL
reconstituted	NULL
with	NULL
the	NULL
wild-type	NULL
HSC	NULL
.	NULL

Cells	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
blood	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
B-cell	NULL
marker	NULL
(	NULL
B220	NULL
)	NULL
and	NULL
a	NULL
myeloid	NULL
cell	NULL
marker	NULL
(	NULL
Mac1	NULL
)	NULL
.	NULL

Donor	NULL
cells	NULL
were	NULL
derived	NULL
from	NULL
wild-type	NULL
C57BL/6Ly5A	NULL
mice	NULL
and	NULL
were	NULL
negative	NULL
for	NULL
CD45.2	NULL
,	NULL
whereas	NULL
host	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
CD45.2	NULL
marker	NULL
.	NULL

Gating	NULL
and	NULL
data	NULL
presentation	NULL
are	NULL
as	NULL
in	NULL
panel	NULL
A.	NULL
type	NULL
littermates	NULL
,	NULL
nearly	NULL
reaching	NULL
the	NULL
B-cell	NULL
number	NULL
in	NULL
age-matched	NULL
E2A*Â°	NULL
heterozygous	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
log	NULL
scale	NULL
increase	NULL
of	NULL
B-cell	NULL
numbers	NULL
from	NULL
mice	NULL
carrying	NULL
one	NULL
copy	NULL
of	NULL
E2A	NULL
``	NULL
Â®	NULL
``	NULL
to	NULL
mice	NULL
carrying	NULL
two	NULL
copies	NULL
of	NULL
E2A	NULL
``	NULL
``	NULL
strongly	NULL
argues	NULL
that	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
E	NULL
proteins	NULL
is	NULL
critical	NULL
and	NULL
essential	NULL
for	NULL
B-cell	NULL
commitment	NULL
.	NULL

DISCUSSION	NULL
E2A	NULL
encodes	NULL
two	NULL
broadly	NULL
expressed	NULL
bHLH	NULL
proteins	NULL
that	NULL
play	NULL
specific	NULL
and	NULL
essential	NULL
roles	NULL
in	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

How	NULL
functional	NULL
specificity	NULL
is	NULL
achieved	NULL
by	NULL
the	NULL
E2A	NULL
gene	NULL
is	NULL
central	NULL
to	NULL
our	NULL
understanding	NULL
of	NULL
E2A-mediated	NULL
regulatory	NULL
pathways	NULL
in	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

B-cell-specific	NULL
posttranslational	NULL
modification	NULL
of	NULL
E47	NULL
has	NULL
been	NULL
postulated	NULL
as	NULL
a	NULL
major	NULL
event	NULL
in	NULL
regulating	NULL
EZ2A	NULL
protein	NULL
activity	NULL
,	NULL
which	NULL
in	NULL
principle	NULL
provides	NULL
the	NULL
needed	NULL
functional	NULL
specificity	NULL
.	NULL

This	NULL
model	NULL
suggests	NULL
that	NULL
the	NULL
functional	NULL
specificity	NULL
of	NULL
E2A	NULL
is	NULL
mediated	NULL
by	NULL
E47	NULL
homodimerization	NULL
,	NULL
which	NULL
is	NULL
detected	NULL
exclusively	NULL
in	NULL
B-lineage	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
model	NULL
suggests	NULL
that	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
E47-specific	NULL
exon	NULL
provides	NULL
the	NULL
functional	NULL
specificity	NULL
and	NULL
excludes	NULL
any	NULL
functional	NULL
significance	NULL
of	NULL
E12	NULL
and	NULL
other	NULL
E	NULL
proteins	NULL
in	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

This	NULL
model	NULL
is	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
A	NULL
Replacement	NULL
of	NULL
the	NULL
mouse	NULL
E2A	NULL
gene	NULL
with	NULL
a	NULL
human	NULL
HEB	NULL
cDNA	NULL
kb	NULL
BZA	NULL
--	NULL
Â»	NULL
E12	NULL
E47	NULL
_	NULL
3'stop	NULL
EA	NULL
wt	NULL
-	NULL
a	NULL
___	NULL
_5	NULL
5	NULL
_	NULL
m	NULL
w	NULL
___	NULL
Kpn	NULL
RV	NULL
<	NULL
-	NULL
Xbal	NULL
Bam	NULL
el9	NULL
[	NULL
l	NULL
J	NULL
Eapheb	NULL
or	NULL
(	NULL
Â©	NULL
)	NULL
r	NULL
BJ	NULL
Neo	NULL
|	NULL
IRES-HEE	NULL
__	NULL
(	NULL
S	NULL
]	NULL
;	NULL
4	NULL
Kpn	NULL
RV	NULL
Xbal	NULL
Bam	NULL
-	NULL
>	NULL
Â«	NULL
-yel77	NULL
ya-24	NULL
B	NULL
Expression	NULL
of	NULL
HEB	NULL
proteins	NULL
Thymus	NULL
Spleen	NULL
-	NULL
go	NULL
:	NULL
$	NULL
go	NULL
f	NULL
i	NULL
Â£	NULL
s	NULL
ra-4	NULL
i	NULL
i	NULL
$	NULL
Â£	NULL
i	NULL
508	NULL
Â§	NULL
$	NULL
5	NULL
i	NULL
i	NULL
f	NULL
123	NULL
gg	NULL
-	NULL
0	NULL
``	NULL
**	NULL
*=	NULL
por	NULL
meg	NULL
7754â11153	NULL
50	NULL
C	NULL
Antibody	NULL
supershift	NULL
identifies	NULL
E-protein-DNA	NULL
complex	NULL
wt	NULL
E2Ahcb	NULL
wt	NULL
E2Aheb	NULL
spleen	NULL
spleen	NULL
thymus	NULL
thymus	NULL
antibody	NULL
-	NULL
~	NULL
E	NULL
HO	NULL
>	NULL
E	NULL
Ho	NULL
-	NULL
E	NULL
Ho	NULL
>	NULL
-	NULL
Ho	NULL
ra	NULL
amy	NULL
esp	NULL
Â®	NULL
-	NULL
wore	NULL
H	NULL
g	NULL
<	NULL
-	NULL
HEB	NULL
E2A	NULL
-	NULL
>	NULL
u	NULL
ad	NULL
H	NULL
10	NULL
20	NULL
30	NULL
40	NULL
Â§	NULL
6	NULL
70	NULL
80	NULL
9Â°	NULL
10	NULL
1	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Gene	NULL
targeting	NULL
construct	NULL
for	NULL
generating	NULL
the	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
allele	NULL
.	NULL

The	NULL
Neo	NULL
marker	NULL
was	NULL
introduced	NULL
in	NULL
the	NULL
E2A	NULL
gene	NULL
as	NULL
a	NULL
fusion	NULL
protein	NULL
.	NULL

IRES-driven	NULL
human	NULL
HEB	NULL
cDNA	NULL
was	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
Neo	NULL
cassette	NULL
but	NULL
in	NULL
front	NULL
of	NULL
the	NULL
E2A	NULL
translation	NULL
termination	NULL
site	NULL
.	NULL

Both	NULL
E12	NULL
and	NULL
E47	NULL
exons	NULL
are	NULL
completely	NULL
deleted	NULL
from	NULL
the	NULL
targeting	NULL
construct	NULL
.	NULL

Primers	NULL
used	NULL
for	NULL
PCR	NULL
genotyping	NULL
the	NULL
mutant	NULL
and	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
alleles	NULL
are	NULL
indicated	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Designations	NULL
are	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
thymus	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
and	NULL
spleen	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
nuclear	NULL
extracts	NULL
from	NULL
10-day-old	NULL
neonatal	NULL
mice	NULL
of	NULL
indicated	NULL
genotypes	NULL
.	NULL

Wild-type	NULL
,	NULL
E2A*Â°	NULL
heterozygote	NULL
,	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
heterozygote	NULL
,	NULL
and	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
homozygote	NULL
samples	NULL
are	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
anti-HEB	NULL
polyclonal	NULL
sera	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
cross-react	NULL
with	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
HEB	NULL
proteins	NULL
.	NULL

Size	NULL
markers	NULL
in	NULL
kilodaltons	NULL
and	NULL
the	NULL
HEB	NULL
band	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
and	NULL
right	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel	NULL
shift	NULL
analysis	NULL
of	NULL
E-protein	NULL
complex	NULL
formation	NULL
,	NULL
using	NULL
wE5	NULL
radiolabeled	NULL
probe	NULL
.	NULL

E5	NULL
probe	NULL
(	NULL
25	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
splenocytes	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
or	NULL
thymocytes	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
11	NULL
)	NULL
derived	NULL
from	NULL
wild-type	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
or	NULL
E2A	NULL
``	NULL
``	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
)	NULL
animals	NULL
.	NULL

Anti-E2A	NULL
antibody	NULL
(	NULL
Yae	NULL
)	NULL
was	NULL
added	NULL
in	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
,	NULL
and	NULL
anti-HEB	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
was	NULL
added	NULL
in	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
11	NULL
.	NULL

The	NULL
E2A-and	NULL
HEB-dependent	NULL
supershifts	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
on	NULL
the	NULL
left	NULL
and	NULL
right	NULL
sides	NULL
,	NULL
respectively	NULL
.	NULL

Assay	NULL
conditions	NULL
are	NULL
as	NULL
described	NULL
by	NULL
Sawada	NULL
and	NULL
Littman	NULL
(	NULL
22	NULL
)	NULL
.	NULL

EZA	NULL
THRESHOLD	NULL
CONTROLS	NULL
B-CELL	NULL
LINEAGE	NULL
COMMITMENT	NULL
_	NULL
3347	NULL
E2akop2aheb	NULL
E2abebg2abeb	NULL
3	NULL
Â»	NULL
0.7	NULL
16	NULL
G	NULL
d	NULL
a	NULL
o.s|	NULL
|E	NULL
E	NULL
``	NULL
I	NULL
&	NULL
bs	NULL
o	NULL
A	NULL
o	NULL
3	NULL
C3	NULL
a	NULL
a	NULL
)	NULL
17	NULL
|	NULL
g	NULL
$	NULL
z	NULL
3	NULL
c	NULL
Ja	NULL
1.3	NULL
>	NULL
B220-fite	NULL
B	NULL
50	NULL
E	NULL
wT	NULL
E2Ako/+	NULL
E2Aheb/+	NULL
40	NULL
|-	NULL
E2Ako/E2Aheb	NULL
a	NULL
E2Aheb/E2Aheb	NULL
n=9	NULL
a	NULL
9	NULL
9	NULL
56	NULL
d	NULL
9	NULL
Â£	NULL
mh	NULL
LA	NULL
Â©	NULL
#	NULL
Bone	NULL
marrow	NULL
Spleen	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
FACS	NULL
analysis	NULL
of	NULL
mice	NULL
carrying	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
E2A	NULL
``	NULL
*	NULL
.	NULL

Bone	NULL
marrow	NULL
(	NULL
top	NULL
two	NULL
panels	NULL
)	NULL
and	NULL
spleens	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
from	NULL
10-day-old	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
E2A*Â°/E2A	NULL
``	NULL
*	NULL
``	NULL
transheterozygous	NULL
,	NULL
and	NULL
E2A	NULL
``	NULL
*	NULL
``	NULL
homozygous	NULL
mice	NULL
were	NULL
analyzed	NULL
with	NULL
B-cell	NULL
markers	NULL
.	NULL

Plots	NULL
were	NULL
gated	NULL
on	NULL
live	NULL
lymphocytes	NULL
based	NULL
on	NULL
cell	NULL
size	NULL
and	NULL
7AAD	NULL
staining	NULL
.	NULL

Percentages	NULL
of	NULL
cells	NULL
shown	NULL
in	NULL
the	NULL
quadrants	NULL
represent	NULL
the	NULL
fractions	NULL
of	NULL
total	NULL
live	NULL
cells	NULL
analyzed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
B-cell	NULL
contents	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
total	NULL
live	NULL
suspension	NULL
cells	NULL
for	NULL
the	NULL
five	NULL
genotypes	NULL
.	NULL

Percentages	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
bone	NULL
marrow	NULL
and	NULL
spleen	NULL
are	NULL
calculated	NULL
based	NULL
on	NULL
the	NULL
analysis	NULL
of	NULL
multiple	NULL
litters	NULL
with	NULL
ages	NULL
ranging	NULL
from	NULL
1	NULL
to	NULL
3	NULL
weeks	NULL
.	NULL

Sample	NULL
size	NULL
and	NULL
standard	NULL
deviation	NULL
are	NULL
shown	NULL
with	NULL
each	NULL
data	NULL
bar	NULL
.	NULL

Relatively	NULL
large	NULL
standard	NULL
deviations	NULL
for	NULL
most	NULL
spleen	NULL
samples	NULL
are	NULL
due	NULL
to	NULL
a	NULL
sharp	NULL
increase	NULL
of	NULL
B-cell	NULL
content	NULL
in	NULL
the	NULL
first	NULL
3	NULL
weeks	NULL
of	NULL
postnatal	NULL
life	NULL
.	NULL

challenged	NULL
by	NULL
a	NULL
transgenic	NULL
rescuing	NULL
test	NULL
carried	NULL
out	NULL
by	NULL
Bain	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
and	NULL
is	NULL
further	NULL
questioned	NULL
by	NULL
two	NULL
pieces	NULL
of	NULL
genetic	NULL
evidence	NULL
reported	NULL
here	NULL
.	NULL

First	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
either	NULL
E12	NULL
or	NULL
E47	NULL
alone	NULL
is	NULL
capable	NULL
of	NULL
supporting	NULL
limited	NULL
but	NULL
definitive	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
by	NULL
gene	NULL
replacement	NULL
that	NULL
HEB	NULL
can	NULL
replace	NULL
the	NULL
function	NULL
of	NULL
E2A	NULL
in	NULL
driving	NULL
B-cell	NULL
commitment	NULL
and	NULL
maturation	NULL
.	NULL

Both	NULL
findings	NULL
favor	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
functional	NULL
specificity	NULL
of	NULL
EZA	NULL
is	NULL
largely	NULL
determined	NULL
at	NULL
the	NULL
transcription	NULL
level	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

Functional	NULL
requirement	NULL
of	NULL
E47	NULL
and	NULL
E12	NULL
throughout	NULL
B-cell	NULL
development	NULL
.	NULL

Although	NULL
E47	NULL
or	NULL
E12	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
B-cell	NULL
commitment	NULL
and	NULL
differentiation	NULL
into	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
entire	NULL
process	NULL
is	NULL
extremely	NULL
inefficient	NULL
.	NULL

Pro-B	NULL
,	NULL
pre-B	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
are	NULL
generated	NULL
in	NULL
both	NULL
EA47	NULL
``	NULL
``	NULL
and	NULL
E12*Â°	NULL
mice	NULL
but	NULL
at	NULL
levels	NULL
more	NULL
than	NULL
10-fold	NULL
lower	NULL
than	NULL
in	NULL
their	NULL
wild	NULL
3348	NULL
ZHUANG	NULL
ET	NULL
AL	NULL
.	NULL

type	NULL
littermates	NULL
.	NULL

In	NULL
wild-type	NULL
mice	NULL
,	NULL
pro-B	NULL
cells	NULL
represent	NULL
only	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
the	NULL
total	NULL
population	NULL
of	NULL
B-lineage	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
most	NULL
B-lineage	NULL
cells	NULL
detected	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
of	NULL
E47	NULL
and	NULL
E12	NULL
knockout	NULL
mice	NULL
are	NULL
B220	NULL
*	NULL
CD43+*	NULL
CD19*	NULL
pro-B	NULL
cells	NULL
.	NULL

The	NULL
unbalanced	NULL
ratio	NULL
of	NULL
pro-B	NULL
versus	NULL
pre-B	NULL
cells	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
EZA	NULL
proteins	NULL
in	NULL
differentiation	NULL
from	NULL
pro-B	NULL
to	NULL
pre-B	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
well	NULL
established	NULL
that	NULL
transition	NULL
from	NULL
pro-B	NULL
to	NULL
pre-B	NULL
stage	NULL
is	NULL
dependent	NULL
on	NULL
proper	NULL
expression	NULL
and	NULL
selection	NULL
of	NULL
the	NULL
B-cell	NULL
receptor	NULL
genes	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
and	NULL
light-chain	NULL
genes	NULL
,	NULL
the	NULL
terminal	NULL
deoxynucleotide	NULL
transferase	NULL
gene	NULL
,	NULL
and	NULL
surrogate	NULL
light-chain	NULL
genes	NULL
lambda	NULL
5	NULL
and	NULL
V-pre-B	NULL
are	NULL
among	NULL
the	NULL
demonstrated	NULL
targets	NULL
of	NULL
E2A	NULL
(	NULL
6	NULL
,	NULL
23	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
E2A	NULL
proteins	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
unique	NULL
role	NULL
in	NULL
supporting	NULL
B-lineage	NULL
commitment	NULL
,	NULL
may	NULL
play	NULL
a	NULL
much	NULL
broader	NULL
role	NULL
in	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

The	NULL
combined	NULL
dosage	NULL
of	NULL
E47	NULL
and	NULL
E12	NULL
is	NULL
required	NULL
for	NULL
B-cell	NULL
development	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
transheterozygous	NULL
mice	NULL
have	NULL
no	NULL
better	NULL
capacity	NULL
to	NULL
generate	NULL
B	NULL
cells	NULL
than	NULL
E12*Â°	NULL
or	NULL
E47Â°	NULL
``	NULL
homozygous	NULL
mice	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
mere	NULL
presence	NULL
of	NULL
both	NULL
E12	NULL
and	NULL
E47	NULL
proteins	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
support	NULL
normal	NULL
B	NULL
lymphopoiesis	NULL
.	NULL

Comparison	NULL
with	NULL
EZ2A*Â°	NULL
heterozygous	NULL
mice	NULL
which	NULL
also	NULL
carry	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
E47	NULL
and	NULL
E12	NULL
shows	NULL
that	NULL
transheterozygous	NULL
E47Â°	NULL
``	NULL
/E12**	NULL
is	NULL
composed	NULL
of	NULL
an	NULL
E47	NULL
``	NULL
allele	NULL
.	NULL

However	NULL
,	NULL
the	NULL
EZ2A*Â°	NULL
heterozygous	NULL
mice	NULL
can	NULL
produce	NULL
50	NULL
%	NULL
wild-type	NULL
levels	NULL
of	NULL
pro-	NULL
and	NULL
pre-B	NULL
cells	NULL
in	NULL
fetal	NULL
and	NULL
neonatal	NULL
life	NULL
and	NULL
near	NULL
normal	NULL
levels	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
adult	NULL
life	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
phenotypic	NULL
discrepancy	NULL
between	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
and	NULL
heterozygous	NULL
mice	NULL
may	NULL
be	NULL
partially	NULL
due	NULL
to	NULL
inadvertent	NULL
reduction	NULL
of	NULL
E12	NULL
and	NULL
E47	NULL
expression	NULL
from	NULL
the	NULL
mutated	NULL
E47	NULL
``	NULL
and	NULL
E12Â®*	NULL
alleles	NULL
,	NULL
respectively	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
discrepancy	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
from	NULL
the	NULL
E47	NULL
``	NULL
allele	NULL
;	NULL
e.g	NULL
.	NULL

,	NULL
E47Â°	NULL
``	NULL
may	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
E12	NULL
and	NULL
E47	NULL
through	NULL
competitive	NULL
dimerization	NULL
.	NULL

In	NULL
either	NULL
case	NULL
,	NULL
the	NULL
end	NULL
result	NULL
is	NULL
a	NULL
further	NULL
reduction	NULL
of	NULL
functional	NULL
E	NULL
proteins	NULL
below	NULL
one-half	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
in	NULL
the	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
mice	NULL
.	NULL

Perhaps	NULL
this	NULL
subtle	NULL
difference	NULL
in	NULL
the	NULL
level	NULL
of	NULL
functional	NULL
E2A	NULL
proteins	NULL
is	NULL
sufficient	NULL
to	NULL
trigger	NULL
a	NULL
threshold	NULL
effect	NULL
,	NULL
leading	NULL
to	NULL
inefficient	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
the	NULL
E47Â°	NULL
``	NULL
/E12*Â°	NULL
mice	NULL
.	NULL

Function	NULL
by	NULL
context	NULL
rather	NULL
than	NULL
by	NULL
a	NULL
unique	NULL
structure	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
functional	NULL
specificity	NULL
among	NULL
different	NULL
E-protein	NULL
genes	NULL
is	NULL
supported	NULL
by	NULL
gene	NULL
knockout	NULL
studies	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
how	NULL
functional	NULL
specificity	NULL
for	NULL
each	NULL
E-protein	NULL
gene	NULL
is	NULL
defined	NULL
and	NULL
regulated	NULL
.	NULL

Because	NULL
all	NULL
three	NULL
E-protein	NULL
genes	NULL
are	NULL
broadly	NULL
,	NULL
although	NULL
not	NULL
evenly	NULL
,	NULL
expressed	NULL
in	NULL
different	NULL
tissues	NULL
,	NULL
transcriptional	NULL
regulation	NULL
has	NULL
been	NULL
generally	NULL
discounted	NULL
as	NULL
a	NULL
way	NULL
to	NULL
achieve	NULL
functional	NULL
specificity	NULL
.	NULL

All	NULL
of	NULL
the	NULL
evidence	NULL
accumulated	NULL
prior	NULL
to	NULL
this	NULL
study	NULL
favors	NULL
the	NULL
notion	NULL
that	NULL
functional	NULL
specificity	NULL
of	NULL
EZA	NULL
in	NULL
B-cell	NULL
development	NULL
is	NULL
determined	NULL
mainly	NULL
by	NULL
a	NULL
unique	NULL
structure	NULL
of	NULL
E2A	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
E47	NULL
protein	NULL
(	NULL
5	NULL
,	NULL
25	NULL
)	NULL
.	NULL

HEB	NULL
and	NULL
E2-2	NULL
can	NULL
modulate	NULL
E2A	NULL
activity	NULL
in	NULL
two	NULL
possible	NULL
ways	NULL
:	NULL
they	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
E12	NULL
and	NULL
E47	NULL
through	NULL
heterodimerization	NULL
(	NULL
1	NULL
,	NULL
22	NULL
)	NULL
or	NULL
indirectly	NULL
affect	NULL
E2A	NULL
activity	NULL
through	NULL
interactions	NULL
with	NULL
the	NULL
Id	NULL
proteins	NULL
(	NULL
28	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Since	NULL
mice	NULL
lacking	NULL
either	NULL
HEB	NULL
or	NULL
E2-2	NULL
can	NULL
still	NULL
generate	NULL
a	NULL
substantial	NULL
number	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
,	NULL
these	NULL
presumed	NULL
functions	NULL
of	NULL
HEB	NULL
and	NULL
E2-2	NULL
are	NULL
apparently	NULL
nonessential	NULL
.	NULL

A	NULL
functional	NULL
replacement	NULL
of	NULL
E2A	NULL
with	NULL
HEB	NULL
,	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
,	NULL
argues	NULL
that	NULL
HEB	NULL
,	NULL
EZA	NULL
,	NULL
and	NULL
perhaps	NULL
E2-2	NULL
as	NULL
well	NULL
share	NULL
a	NULL
common	NULL
protein	NULL
structure	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
support	NULL
B-cell	NULL
commitment	NULL
and	NULL
maturation	NULL
.	NULL

This	NULL
finding	NULL
challenges	NULL
the	NULL
existing	NULL
hypothesis	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
functional	NULL
specificity	NULL
of	NULL
E2A	NULL
is	NULL
determined	NULL
primarily	NULL
by	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

Threshold	NULL
regulation-from	NULL
Drosophila	NULL
to	NULL
mice	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
among	NULL
different	NULL
E	NULL
proteins	NULL
at	NULL
both	NULL
structural	NULL
and	NULL
functional	NULL
levels	NULL
argues	NULL
that	NULL
E	NULL
proteins	NULL
must	NULL
play	NULL
fundamental	NULL
roles	NULL
during	NULL
development	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
this	NULL
conserva-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

tion	NULL
of	NULL
E	NULL
proteins	NULL
can	NULL
be	NULL
traced	NULL
back	NULL
to	NULL
invertebrates	NULL
such	NULL
as	NULL
Drosophila	NULL
,	NULL
in	NULL
which	NULL
a	NULL
single	NULL
E-protein-equivalent	NULL
bHLH	NULL
gene	NULL
known	NULL
as	NULL
daughterless	NULL
was	NULL
found	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
daughterless	NULL
is	NULL
involved	NULL
in	NULL
regulating	NULL
differentiation	NULL
events	NULL
such	NULL
as	NULL
sex	NULL
determination	NULL
in	NULL
a	NULL
dosage-dependent	NULL
manner	NULL
(	NULL
7	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
differentiation	NULL
events	NULL
by	NULL
daughterless	NULL
in	NULL
invertebrates	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
dosage-dependent	NULL
regulation	NULL
of	NULL
B-cell	NULL
development	NULL
by	NULL
the	NULL
E	NULL
proteins	NULL
in	NULL
mammals	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
a	NULL
critical	NULL
level	NULL
of	NULL
bHLH	NULL
proteins	NULL
is	NULL
required	NULL
to	NULL
trigger	NULL
a	NULL
binary	NULL
switch	NULL
leading	NULL
to	NULL
irreversible	NULL
differentiation	NULL
events	NULL
,	NULL
namely	NULL
,	NULL
establishment	NULL
of	NULL
the	NULL
female	NULL
body	NULL
plan	NULL
in	NULL
Drosophila	NULL
and	NULL
the	NULL
B-cell	NULL
lineage	NULL
in	NULL
mice	NULL
.	NULL

This	NULL
structural	NULL
and	NULL
functional	NULL
conservation	NULL
between	NULL
the	NULL
fly	NULL
daughterless	NULL
gene	NULL
and	NULL
the	NULL
mouse	NULL
E2A	NULL
gene	NULL
suggests	NULL
that	NULL
the	NULL
threshold	NULL
mechanism	NULL
may	NULL
be	NULL
more	NULL
generally	NULL
used	NULL
by	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
other	NULL
cell	NULL
lineages	NULL
.	NULL

Why	NULL
three	NULL
functionally	NULL
equivalent	NULL
E-protein	NULL
genes	NULL
?	NULL

This	NULL
study	NULL
also	NULL
poses	NULL
an	NULL
important	NULL
question	NULL
:	NULL
why	NULL
do	NULL
mammals	NULL
need	NULL
three	NULL
functionally	NULL
equivalent	NULL
E-protein	NULL
genes	NULL
?	NULL

For	NULL
simplicity	NULL
,	NULL
we	NULL
discuss	NULL
only	NULL
the	NULL
common	NULL
roles	NULL
shared	NULL
by	NULL
these	NULL
E	NULL
proteins	NULL
,	NULL
although	NULL
subtle	NULL
differences	NULL
,	NULL
such	NULL
as	NULL
dimerization	NULL
specificity	NULL
and	NULL
affinity	NULL
to	NULL
specific	NULL
DNA	NULL
sites	NULL
,	NULL
clearly	NULL
exist	NULL
.	NULL

It	NULL
may	NULL
be	NULL
argued	NULL
that	NULL
a	NULL
functional	NULL
diversification	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
may	NULL
not	NULL
be	NULL
tolerated	NULL
if	NULL
the	NULL
ancestor	NULL
E	NULL
protein	NULL
plays	NULL
a	NULL
fundamental	NULL
role	NULL
which	NULL
has	NULL
been	NULL
fixed	NULL
in	NULL
evolution	NULL
.	NULL

Our	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
function	NULL
of	NULL
the	NULL
E	NULL
proteins	NULL
,	NULL
although	NULL
fixed	NULL
,	NULL
is	NULL
subject	NULL
to	NULL
tissue	NULL
specific	NULL
regulation	NULL
.	NULL

The	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
,	NULL
perhaps	NULL
,	NULL
only	NULL
one	NULL
of	NULL
many	NULL
tissue-specific	NULL
regulation	NULL
events	NULL
that	NULL
have	NULL
occurred	NULL
during	NULL
embryonic	NULL
and	NULL
tissue	NULL
development	NULL
;	NULL
each	NULL
event	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
unique	NULL
enhancer	NULL
(	NULL
or	NULL
a	NULL
unique	NULL
set	NULL
of	NULL
enhancers	NULL
)	NULL
attached	NULL
to	NULL
the	NULL
gene	NULL
.	NULL

Intuitively	NULL
,	NULL
there	NULL
may	NULL
be	NULL
a	NULL
limit	NULL
for	NULL
how	NULL
many	NULL
tissue-specific	NULL
enhancers	NULL
can	NULL
be	NULL
added	NULL
to	NULL
a	NULL
single	NULL
gene	NULL
.	NULL

We	NULL
argue	NULL
that	NULL
gene	NULL
duplication	NULL
may	NULL
be	NULL
a	NULL
simple	NULL
way	NULL
to	NULL
accommodate	NULL
the	NULL
increasing	NULL
need	NULL
for	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
the	NULL
conserved	NULL
function	NULL
provided	NULL
by	NULL
the	NULL
ancestor	NULL
E-protein	NULL
gene	NULL
.	NULL

This	NULL
interpretation	NULL
predicts	NULL
that	NULL
as	NULL
important	NULL
as	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
EZA	NULL
gene	NULL
is	NULL
to	NULL
B-cell	NULL
development	NULL
,	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HEB	NULL
and	NULL
E2Z-2	NULL
genes	NULL
may	NULL
be	NULL
important	NULL
to	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Peifeng	NULL
Cheng	NULL
for	NULL
assistance	NULL
in	NULL
generating	NULL
the	NULL
E47	NULL
``	NULL
mutation	NULL
,	NULL
Mike	NULL
Krangel	NULL
and	NULL
Mike	NULL
Krause	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
Billie	NULL
Maciunas	NULL
for	NULL
editorial	NULL
assistance	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Duke	NULL
Cancer	NULL
Center	NULL
Flow	NULL
Cytometry	NULL
Facility	NULL
for	NULL
technical	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
initiated	NULL
with	NULL
a	NULL
fellowship	NULL
award	NULL
from	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
to	NULL
Y.Z	NULL
.	NULL

and	NULL
supported	NULL
by	NULL
a	NULL
Whitehead	NULL
Scholarship	NULL
and	NULL
an	NULL
NCJ	NULL
grant	NULL
(	NULL
RO1CA72433-01	NULL
)	NULL
to	NULL
Y.Z	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Gruenwald	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

E2A	NULL
and	NULL
E2-2	NULL
are	NULL
subunits	NULL
of	NULL
B-cell-specific	NULL
E2-box	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3522-3529	NULL
.	NULL

2	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
D.	NULL
J.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
B.	NULL
C.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
H.	NULL
P.	NULL
J.	NULL
te	NULL
Riele	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

3	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
H.	NULL
P.	NULL
te	NULL
Riele	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
A.	NULL
Sheehy	NULL
,	NULL
M.	NULL
Schlissel	NULL
,	NULL
S.	NULL
A.	NULL
Shinton	NULL
,	NULL
R.	NULL
R.	NULL
Hardy	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1997	NULL
.	NULL

Both	NULL
E12	NULL
and	NULL
E47	NULL
allow	NULL
commitment	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
.	NULL

Immunity	NULL
6:145-154	NULL
.	NULL

4	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
D.	NULL
L.	NULL
Turner	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
61:49-59	NULL
.	NULL

5	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

An	NULL
intermolecular	NULL
disulfide	NULL
bond	NULL
stabilizes	NULL
E2A	NULL
homodimers	NULL
and	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
at	NULL
physiological	NULL
temperatures	NULL
.	NULL

Cell	NULL
79:1057-1067	NULL
.	NULL

6	NULL
.	NULL

Choi	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
C.	NULL
P.	NULL
Shen	NULL
,	NULL
H.	NULL
S.	NULL
Radomska	NULL
,	NULL
L.	NULL
A.	NULL
Eckhardt	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1996	NULL
.	NULL

E47	NULL
activates	NULL
the	NULL
Ig-heavy	NULL
chain	NULL
and	NULL
TdT	NULL
loci	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:5014-5021	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21.	NULL
.	NULL

Cline	NULL
,	NULL
T.	NULL
W.	NULL
1989	NULL
.	NULL

The	NULL
affairs	NULL
of	NULL
daughterless	NULL
and	NULL
the	NULL
promiscuity	NULL
of	NULL
devel-	NULL
opmental	NULL
regulation	NULL
.	NULL

Cell	NULL
59:231-234.	NULL
.	NULL

Gu	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
and	NULL
K.	NULL
Rajewsky	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
development	NULL
regulated	NULL
by	NULL
gene	NULL
rearrangement	NULL
:	NULL
arrest	NULL
of	NULL
maturation	NULL
by	NULL
membrane-bound	NULL
D	NULL
mu	NULL
protein	NULL
and	NULL
selection	NULL
of	NULL
DH	NULL
element	NULL
reading	NULL
frames	NULL
.	NULL

Cell	NULL
65:47-54.	NULL
.	NULL

Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
C.	NULL
E.	NULL
Carmack	NULL
,	NULL
S.	NULL
A.	NULL
Shinton	NULL
,	NULL
J.	NULL
D.	NULL
Kemp	NULL
,	NULL
and	NULL
K.	NULL
Hayakawa	NULL
.	NULL

1991	NULL
.	NULL

Resolution	NULL
and	NULL
characterization	NULL
of	NULL
pro-B	NULL
and	NULL
pre-pro-B-cell	NULL
stages	NULL
in	NULL
normal	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:1213-1225	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Kiledjian	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
wES5/kE2	NULL
motif	NULL
.	NULL

Science	NULL
247:467-470	NULL
.	NULL

Hu	NULL
,	NULL
J.-S.	NULL
,	NULL
E.	NULL
N.	NULL
Olson	NULL
,	NULL
and	NULL
R.	NULL
E.	NULL
Kingston	NULL
.	NULL

1992	NULL
.	NULL

HEB	NULL
,	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
related	NULL
to	NULL
E2A	NULL
and	NULL
ITF2	NULL
that	NULL
can	NULL
modulate	NULL
the	NULL
DNA-binding	NULL
ability	NULL
of	NULL
myogenic	NULL
regulatory	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1031-1042	NULL
.	NULL

Jang	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
E.	NULL
Wimmer	NULL
.	NULL

1990	NULL
.	NULL

Cap-independent	NULL
translation	NULL
of	NULL
encephalomyocarditis	NULL
virus	NULL
RNA	NULL
:	NULL
structural	NULL
elements	NULL
of	NULL
the	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
and	NULL
involvement	NULL
of	NULL
a	NULL
cellular	NULL
57-kD	NULL
RNA-binding	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1560-1572	NULL
.	NULL

Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
C.	NULL
Murre	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
A.	NULL
Voronova	NULL
,	NULL
W.	NULL
E.	NULL
Wright	NULL
,	NULL
D.	NULL
Balti-more	NULL
,	NULL
T.	NULL
Kadesch	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
activity	NULL
of	NULL
myogenic	NULL
HLH	NULL
proteins	NULL
requires	NULL
hetero-oligomerization	NULL
with	NULL
E12/E47-like	NULL
proteins	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
66:305-315	NULL
.	NULL

Lin	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Failure	NULL
of	NULL
B-cell	NULL
differentiation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
EBF	NULL
.	NULL

Nature	NULL
376:263-267	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
mye	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
H.	NULL
Vaessin	NULL
,	NULL
M.	NULL
Caudy	NULL
,	NULL
L.	NULL
Y.	NULL
Jan	NULL
,	NULL
Y.	NULL
N.	NULL
Jan	NULL
,	NULL
C.	NULL
V.	NULL
Cabrera	NULL
,	NULL
J.	NULL
N.	NULL
Buskin	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Interactions	NULL
between	NULL
heterodimeric	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537-544	NULL
.	NULL

Parkhurst	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
H.	NULL
D.	NULL
Lipshitz	NULL
,	NULL
and	NULL
D.	NULL
Ish-Horowicz	NULL
.	NULL

1993	NULL
.	NULL

Achacte-scute	NULL
feminizing	NULL
activities	NULL
and	NULL
Drosophila	NULL
sex	NULL
determination	NULL
.	NULL

Development	NULL
117	NULL
:	NULL
737-749	NULL
.	NULL

Rolink	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
F.	NULL
Melchers	NULL
.	NULL

1993	NULL
.	NULL

B	NULL
lymphopoiesis	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

53:123-156	NULL
.	NULL

Rolink	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
ten	NULL
Boekel	NULL
,	NULL
F.	NULL
Melchers	NULL
,	NULL
D.	NULL
T.	NULL
Fearon	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
and	NULL
J.	NULL
Anders-son	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
subpopulation	NULL
of	NULL
B220+	NULL
cells	NULL
in	NULL
murine	NULL
bone	NULL
marrow	NULL
does	NULL
not	NULL
express	NULL
CD19	NULL
and	NULL
contains	NULL
natural	NULL
killer	NULL
cell	NULL
progenitors	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
:	NULL
187-194	NULL
.	NULL

Rupp	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1991	NULL
.	NULL

Ubiquitous	NULL
MyoD	NULL
transcription	NULL
at	NULL
the	NULL
midblastula	NULL
transition	NULL
precedes	NULL
induction-dependent	NULL
MyoD	NULL
expression	NULL
in	NULL
presumptive	NULL
mesoderm	NULL
of	NULL
X.	NULL
laevis	NULL
.	NULL

Cell	NULL
65:927-937	NULL
.	NULL

Sato	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
Ono	NULL
,	NULL
D.	NULL
A.	NULL
Steeber	NULL
,	NULL
D.	NULL
S.	NULL
Pisetsky	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1996	NULL
.	NULL

CD19	NULL
regulates	NULL
B	NULL
lymphocyte	NULL
signaling	NULL
thresholds	NULL
critical	NULL
for	NULL
the	NULL
development	NULL
of	NULL
B-1	NULL
lincage	NULL
cells	NULL
and	NULL
autoimmunity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

15:4371-4378	NULL
.	NULL

EZA	NULL
THRESHOLD	NULL
CONTROLS	NULL
B-CELL	NULL
LINEAGE	NULL
COMMITMENT	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

3349	NULL
Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
heterodimer	NULL
of	NULL
HEB	NULL
and	NULL
an	NULL
E12-related	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
CD4	NULL
enhancer	NULL
and	NULL
regulates	NULL
its	NULL
activity	NULL
in	NULL
T-cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5620-5628	NULL
.	NULL

Schlissel	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Voronova	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Helix-loop-helix	NULL
transcription	NULL
factor	NULL
E47	NULL
activates	NULL
germ-line	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
transcription	NULL
and	NULL
rearrangement	NULL
in	NULL
a	NULL
pre-T-cell	NULL
line	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1367-1376	NULL
.	NULL

Schlissel	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
L.	NULL
M.	NULL
Corcoran	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Virus-transformed	NULL
pre-B	NULL
cells	NULL
show	NULL
ordered	NULL
activation	NULL
but	NULL
not	NULL
inactivation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangement	NULL
and	NULL
transcription	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:711-720.	NULL
.	NULL

Shen	NULL
,	NULL
C.-P.	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1995	NULL
.	NULL

B-cell-specific	NULL
DNA	NULL
binding	NULL
by	NULL
an	NULL
E47	NULL
homodimer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15145184524	NULL
.	NULL

Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
O'Riordan	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1997	NULL
.	NULL

EBF	NULL
and	NULL
E47	NULL
collaborate	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
immunoglobulin	NULL
surrogate	NULL
light	NULL
chain	NULL
genes	NULL
.	NULL

Immunity	NULL
7:25-36	NULL
.	NULL

Sun	NULL
,	NULL
X.-H.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
inhibitory	NULL
domain	NULL
of	NULL
E12	NULL
transcription	NULL
factor	NULL
prevents	NULL
DNA	NULL
binding	NULL
in	NULL
E12	NULL
homodimers	NULL
but	NULL
not	NULL
in	NULL
E12	NULL
het-crodimers	NULL
.	NULL

Cell	NULL
64:459-470	NULL
.	NULL

Sun	NULL
,	NULL
X.-H.	NULL
1994	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
Id1	NULL
genes	NULL
impairs	NULL
mouse	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
79:893-900	NULL
.	NULL

Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Z.-Q	NULL
.	NULL

Wang	NULL
,	NULL
I.	NULL
Fetka	NULL
,	NULL
E.	NULL
Wagner	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1994	NULL
.	NULL

Complete	NULL
block	NULL
of	NULL
early	NULL
B	NULL
cell	NULL
differentiation	NULL
and	NULL
altered	NULL
patterning	NULL
of	NULL
the	NULL
posterior	NULL
midbrain	NULL
in	NULL
mice	NULL
lacking	NULL
Pax5/BSAP	NULL
.	NULL

Cell	NULL
79:901-912	NULL
.	NULL

Voronova	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Mutations	NULL
that	NULL
disrupt	NULL
DNA	NULL
binding	NULL
and	NULL
dimer	NULL
formation	NULL
in	NULL
the	NULL
E47	NULL
helix-loop-helix	NULL
protein	NULL
map	NULL
to	NULL
distinct	NULL
domains	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4722-4726	NULL
.	NULL

Wang	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
A.	NULL
Nichogiannopoulou	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
L.	NULL
Sun	NULL
,	NULL
A.	NULL
H.	NULL
Sharpe	NULL
,	NULL
M.	NULL
Bighy	NULL
,	NULL
and	NULL
K.	NULL
Georgopoulos	NULL
.	NULL

1996	NULL
.	NULL

Selective	NULL
defects	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
fetal	NULL
and	NULL
adult	NULL
lymphoid	NULL
system	NULL
in	NULL
mice	NULL
with	NULL
an	NULL
Ikaros	NULL
null	NULL
mutation	NULL
.	NULL

Immunity	NULL
51537-549	NULL
.	NULL

Wilson	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
M.	NULL
Kiledjian	NULL
,	NULL
C.	NULL
P.	NULL
Shen	NULL
,	NULL
R.	NULL
Benezra	NULL
,	NULL
P.	NULL
Zwollo	NULL
,	NULL
S.	NULL
M.	NULL
Dymecki	NULL
,	NULL
S.	NULL
V.	NULL
D	NULL
io	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1991	NULL
.	NULL

Repression	NULL
of	NULL
immunoglobulin	NULL
enhancers	NULL
by	NULL
the	NULL
helix-loop-helix	NULL
protein	NULL
Id	NULL
:	NULL
implications	NULL
for	NULL
B	NULL
lymphoid	NULL
development	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:6185-6191	NULL
.	NULL

Yan	NULL
,	NULL
W.	NULL
,	NULL
A	NULL
.	NULL

Z	NULL
.	NULL

Young	NULL
,	NULL
Y.	NULL
C.	NULL
Soares	NULL
,	NULL
R.	NULL
Kelley	NULL
,	NULL
R.	NULL
Benezra	NULL
,	NULL
and	NULL
Y.	NULL
Zhuang	NULL
.	NULL

1997	NULL
.	NULL

High	NULL
incidence	NULL
of	NULL
T-cell	NULL
tumors	NULL
in	NULL
E2A-null	NULL
mice	NULL
and	NULL
E2A/Id1	NULL
double	NULL
knockout	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:7317-7327	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
G.	NULL
Kim	NULL
,	NULL
S.	NULL
Bartelmez	NULL
,	NULL
P.	NULL
Cheng	NULL
,	NULL
M.	NULL
Groudine	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1992	NULL
.	NULL

Helix-loop-helix	NULL
transcription	NULL
factors	NULL
E12	NULL
and	NULL
E47	NULL
are	NULL
not	NULL
essential	NULL
for	NULL
skeletal	NULL
or	NULL
cardiac	NULL
myogenesis	NULL
,	NULL
erythropoiesis	NULL
,	NULL
chondrogenesis	NULL
,	NULL
or	NULL
neurogenesis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:12132-12136	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875-884	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
F.	NULL
Cheng	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1996	NULL
.	NULL

B-lymphocyte	NULL
development	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
combined	NULL
dosage	NULL
of	NULL
three	NULL
bHLH	NULL
genes	NULL
,	NULL
E2A	NULL
,	NULL
E2-2	NULL
,	NULL
and	NULL
HEB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2898-2905	NULL
.	NULL

